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GENERAL INTRODUCTION 
Details of mechanisms of intestinal calcium transport and its 
regulation by vitamin D, dietary calcium and vitamin D restriction, 
pregnancy and lactation are still not well understood. For example, several 
recent reports indicated that 1,25-dihydroxyvitamin D3 [1,25-D3] was not 
involved in ATP-dependent basolateral membrane calcium efflux (41) and 
did not enhance intestinal calcium binding protein [CaBP] and calcium 
ATPase [CaATPase] (25,134,138). These observations directly conflict 
with the classical theory that 1,25-D3 binds to specific intracellular vitamin 
D receptors [VDR], to initiate transcription and translation of various 
products (60, 94,102). Moreover, only a few reports on the regulation of 
gene expression of CaATPase by 1,25-D3 in rat and chick intestine have 
been published (5, 21, 170). No reports on the regulation of gene 
expression of CaATPase by the vitamin D2 analog, 1,25,28-D2, have been 
published. The question of whether regulation of both CaATPase and 
CaBP by 1,25-D3 and 1,25,28-D2 were limiting factors in intestinal 
calcium transport was evaluated in the present study. 
The question of whether dietary calcium is a regulator of gene 
2 
expression of calcium transporting factors is still a controversial subject 
which apparently needs further studies. Wasserman et al. (162) 
demonstrated restriction of dietary calcium upregulated intestinal 
CaATPase mRNA in chicks, directly contradictory to a report by Favus et 
al. (41) that ATP-dependent calcium uptake by isolated intestinal 
basolateral membrane vesicles was diminished when the vesicles were 
derived from rats fed calcium-deficient diet. Earlier reports indicated that 
dietary calcium restriction could induce CaBP mRNA expression (6, 7, 42, 
97, 105,113, 133), but recent papers demonstrated calcium restriction did 
not enhance CaBP mRNA expression (55, 136). Therefore, it is of great 
importance to evaluate whether the adaptation to calcium deficiencies 
involves inducing gene expression of intestinal CaATPase and CaBP. 
The active transport of calcium by the intestinal tract is stimulated 
when large amounts of calcium are required during such physiological 
states as pregnancy and lactation (10, 47, 84, 140). Krisinger et al. (74) 
indicated that lactation increased intestinal CaBP mRNA expression. No 
reports have been published on the effects of pregnancy and lactation on 
intestinal CaATPase mRNA expression. Therefore, it is very important to 
determine which components of the intestinal active transport system are 
3 
activated. 
This project was designed to investigate and compare the effects of 
1,25-D3 and 1,25,28-D2 on mRNA expression of CaATPase and CaBP-9K 
in intestinal tissue, to determine whether adaptation to calcium deficiencies 
can induce gene expression of intestinal CaATPase and CaBP, and to study 
which components of intestinal active transport system are activated during 
late pregnancy and early lactation. 
Dissertation Organization 
This dissertation contains a general introduction which includes a 
literature review, three manuscripts and general discussion. The 
references cited in the general introduction are listed at the end of the 
chapter; references cited in each manuscript follow the manuscript. 
Figures and tables follow references [in the appendix]. The three 
manuscripts were written in the style of Infection and Immunity. The 
project was planned and executed, and the manuscripts written, primarily 
by the PhD candidate, Yingting Zhu, with the advice of the major 
professor. Dr. Jesse P. Goff and other conunittee members. 
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Literature Review 
The mechanisms of intestinal calcium transport under physiological 
and pharmacological situations have been extensively studied in recent years. 
A transcellular and a paracellular pathway have been suggested for calcium 
transport in the intestine (17). The transcellular movement is dominant in 
the small intestine, whereas paracellular transport can occur anywhere 
throughout the intestine (107). 
Intestinal calcium transport has the following characteristics: 
1. When dietary calcium is low, active transport accounts for most of 
the calcium absorbed. This transcellular movement involves the diffusional 
entry of calcium into the intestinal mucosa cells across the brush border 
membrane, the diffusional translocation of calcium to the basolateral 
membrane and active extrusion of calcium by primary and secondary active 
calcium pump mechanisms. 
2. Paracellular calcium transport is passive and down its concentration 
gradient. When the calcium concentration in the lumen of the intestine is 
high, the paracellular calcium transfer across the tight junction between 
enterocytes is predominant (37, 105,161). 
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3. Calcium enclosed in membrane-bound vesicles can also be 
transported transcellularly (100). 
The entry of calcium into cells can occur by simple diffusion across 
the membrane driven by the electrochemical gradient for Ca2+, through 
voltage dependent or receptor-operated channels coupled to second 
messengers, or through the Ca2+/Na+ exchanger (2, 160). 
Within cytosol, free calcium is closely regulated by the rate of entry 
and exit of calcium across the plasma membrane. The storage of calcium in 
the form of calcium binding proteins or in the intracellular organelles plays 
an important role in keeping intracellular ionized calcium levels low. 
Because the free calcium level in cytosol is substantially lower than that of 
the extracellular milieu, the final resetting of intracellular calcium must 
involve the extrusion of calcium out of cells through CaATPase and 
Na+/Ca2+ exchangers (112). Compared to CaATPase, the Na+/Ca2+ 
exchanger makes a relatively small contribution to calcium transport. 
The Na+/Ca2+ exchanger may be driven by Na+/K+-ATPase (99). 
It is well known that 1,25-dihydroxyvitamin D3 [1,25-D3] is a 
primary regulator of mineral homeostasis in intestine, bone and kidney (34). 
This includes the induction of calcium binding proteins, basolateral 
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membrane CaATPase and alkaline phosphatase, an increase of calmodulin, 
and changes in membrane lipid composition (11, 51, 114, 167). The overall 
effect of vitamin D is to increase calcium absorption from the intestinal 
tract, to elevate calcium resorption from bones and to enhance the retention 
of calcium from the kidney. Parathyroid hormone stimulates calcium 
absoiption by increasing renal enzyme 25-hydroxyvitamin D3-I-hydroxylase 
(77). Estrogens may also enhance calcium absorption by indirectly 
increasing 1,25-D3 in postmenopausal osteoporosis, pregnancy and lactation 
(45, 62, 73, 85). Other factors may also affect intestinal calcium 
homeostasis independent of vitamin D. For example, Halloran and DeLuca 
(82) reported that pregnancy and lactation increased intestinal calcium 
absoiption even in vitamin D-deficient rats. Calcium must be released from 
the dietary components prior to its absorption, and transported across the 
intestinal enterocytes in a free ionized state (123). Gastric acid may enhance 
calcium solubilization from the diet, thus enhancing dietary calcium 
absorption (86). Exceptionally high dietary fibers may impair calcium 
absorption (117). 
Vitamin D3 is a steroid hormone. The metabolism and mechanism of 
action are similar to other steroid hormones. This vitamin can be derived 
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from the diet or synthesized from 7-dehydrocholesterol in the skin exposed 
to ultraviolet rays from the sun. Under ultraviolet light, the B-ring is 
opened to form previtamin D3, which undergoes thermal equilibration to 
form vitamin D3 (77). Vitamin D3 and its metabolites circulate in the blood 
primarily bound to and in equilibrium with the vitamin D-binding globulin 
(154). The main fimction of the vitamin D-binding globulin is to protect and 
bind vitamin D, facilitate its solubility in the blood and act as a storage-of 
vitamin D, increasing the half life in the body. In the mammalian liver, the 
vitamin is converted to an inactive precursor, 25-hydroxyvitamin D3 [25-
D3], by 25-hydroxylase, a cytochrome P-450-like enzyme. The 
hydroxylation occurs in mitochondria and the microsomal fraction, 
requiring NADPH, O2 and magnesium. In avian species, the intestine and 
kidney are also able to convert vitamin D3 to 25-D3 though this is probably 
of minor consequence (142). The rate of hydroxylation is limited by 25-D3 
feedback inhibition. In circulation 25-D3 has a half life of about 2 to 3 
weeks and can be stored in the liver. When required by the body, 25-D3 is 
converted to the active form, 1,25-D3, by the 1-hydroxylase in the renal 
tubular mitochondria of most mammalian and avian species (77). The 
conversion of 25-D3 to 1,25-D3 requires parathyroid hormone [PTH]. PTH 
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stimulation of 1-hydroxylase is mediated by cAMP, thus enhancing 1,25-D3 
production and intestinal calcium absorption (64, 77). PTH fails to increase 
intestinal calcium transport in vitamin D-deficient rats and humans (8, 46). 
It is clear that the stimulation of intestinal calcium transport by PTH is 
indirect, since it takes hours to develop. This is consistent with the time 
required for activation of the renal 1-hydroxylase to synthesize 1,25-D3 and 
for its effects in the intestine (169). In the absence of PTH, little 1,25-D3 
can be formed and therefore, PTH is an important regulator of vitamin D. 
Conversely 1,25-D3 feedback regulates the parathyroid gland and suppresses 
PTH secretion. The activity of renal 1-hydroxylase can be downregulated by 
increased plasma calcium and 1,25-dihydroxyvitamin D3. Calcium itself has 
a slight inhibitory effect on conversion of 25-D3 to 1,25-D3. Calcium also 
inhibits the secretion of PTH, therefore preventing the conversion of 25-D3 
to 1,25-D3. During pregnancy, the placenta plays a significant role in 
converting 25-D3 to 1,25-D3 (52, 132, 135, 164-166). Alternatively 25-
D3 can be converted by 24-hydroxylase to 24,25-dihydroxyvitamin D3 
[24,25-D3] and other inactive metabolites when calcium and phosphate 
requirements are met. Metabolism of 1,25-D3 occurs by side chain 
oxidation to form an inert 23-carbon acid, calcitroic acid, in liver and 
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intestine or hydroxylation to less active 1,24,25-D3, 1,25,26-D3, 23-oxo-
1,25-D3, 23-0X0-1,26,26-D3 or l,25-D3-23,26 lactone in target tissues such 
as intestine, kidney and cartilage (77). The metabolites are excreted in bile 
and can be reabsorbed in the small intestine, characteristic of an 
enterohepatic circulation. 
1,25-D3 targets its own intracellular vitamin D receptors [VDR], 
which belong to nuclear transcriptional factors of the steroid-thyroid 
receptor gene family (61, 111). The vitamin D receptor consists of a DNA 
binding domam at the amino terminus portion of the protein, a hinge region 
and a steroid binding domain at the carboxy terminus (28). The DNA 
binding domain contains several zinc fingers which are believed to interact 
directly with corresponding DNA. The steroid binding domain is the ligand 
binding domain. The receptor was found in cytosol and nucleus. A high-
affinity, low capacity receptor for 1,25-D3 with a sedimentation coefficient 
of 3.2 S to 3.5 S has been identified from cytosolic homogenates of intestine 
in chicks, rats, human and other species, with highest affinity for 1,25-D3 
and a thousand-fold lower affinity for 25-D3 and other metabolites (18, 59, 
109, 147). Two subspecies of 1,25-D3 receptors of 58 kDa and 60 kDa for 
avian species and two of 52 kDa and 55 kDa for mammalian species have 
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been characterized (30, 110). These were confirmed by in vitro translation 
of 1,25-D3 receptor mRNA (87). The 1,25-D3 receptors are distributed in 
many tissues such as intestine, kidney, bone, brain, breast, cartilage, 
pancreas, parathyroid, pituitary, testis, thymus, thyroid and skin tissues. No 
VDR has been found in neural cells or skeletal muscle (28). The cDNA of 
VDR for rat, chick and human have been cloned (90), making it possible to 
study gene regulation of VDR. 
The action of 1,25-D3 on the VDR is similar to other steroid 
hormones on their receptors. 1,25-D3 can passively enter its target cells, 
bind with cytosolic unoccupied receptors to be ferried into the nucleus or 
diffuse into the nucleus and directly binds to nuclear unoccupied receptors. 
This binding evokes conformational changes that increase receptor affinity 
to specific vitamin D response elements [VDREs] located in the promoter 
region of vitamin D-dependent genes (58, 103, 148). Interaction between 
ligand-receptor complex and VDREs modulates transcription of mRNA 
biology of the cell and thus mediate the vitamin D response. VDREs have 
been identified for the calbindin-9K, rat osteocalcin, mouse osteopontin and 
human osteocalcin genes (28). 
It is very clear that vitamin D exerts its effects on a wide range of 
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issues. Similar to other steroids, the vitamin regulates cellular functions by 
changing gene transcription, mRNA production and stability and protein 
synthesis (154). VDR is a substrate for protein kinase A and other protein 
kinases (28). The phosphorylation of VDR by protein kinase A or other 
protein kinases is required for its activation and transcriptional activity, 
because the phosphorylation of VDR correlates with its ability to activate 
transcription. Interestingly, the phosphorylation was found to occur only at 
serine residues (28). The reason for the phosphorylation at these particular 
sites is unknown. VDR enhances transcellular calcium transport in the 
intestine and kidney, and stimulates bone calcium resorption (35,75, 89, 
102, 116). The hormone-receptcr complex, with other transcriptional 
factors, may increase transcription activities of RNA polymerase II (77). 
Despite the efforts of research scientists for several decades, not all the 
mechanisms of transport nor the controlling factors involving the calcium 
transport process have been found (4, 102). 
The stimulation of calcium uptake in several ceU types by 1,25-D3 has 
been reported. This response can be blocked by cycloheximide and/or 
actinomycin D, providing direct evidence of a transcription related effect 
(3, 70, 168). The effects of 1,25-D3 on calcium uptake among different cell 
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types also differ in magnitude and in time course (3, 149, 168). 
1,25-D3 can also elicit a nongenomic rapid response. The response 
includes transcaltachia and opening of voltage-gated channels. Intracellular 
calcium, cAMP, cGMP and protein kinase C may be involved in these 
processes (29, 31, 32, 163). Nemere and Norman (100) demonstrated that 
1,25-D3 induced a rapid increase in calcium transport in a vascularly 
perfused duodenal preparation from normal chicks. deBoland and Norman 
(33) believe that the response is the result of activation of basolateral calcium 
channels mediated by protein kinase A [PKA] and protein kinase C [PKC]. 
Although the vitamin can activate non-genomic inositol phospholipid 
mechanism to initiate rapid tissue responsiveness, research scientists have 
been making more efforts to illustrate the genomic regulatory mechanisms 
initiated by vitamin D. 
The vitamin D dependency of the nonsaturable components [passive 
transport] of calcium absorption is still controversial. Wasserman et al. 
(163) and Dostal et al. (37) indicated both saturable and nonsaturable 
processes are enhanced by vitamin D. However, not all scientists agree 
(163). 
The vitamin D receptor undergoes autoregulation (27, 81, 104). The 
13 
action of 1,25-D3 could cause transient hypercalcemia, thus suppressing 
PTH secretion. The decreased PTH levels can in turn diminish the synthesis 
of 1,25-D3 (77). Conflicting results have been reported on whether vitamin 
D increases vitamin D receptor mRNA (40,68,91,131). Since injecting 
rats with 1,25-D3 increases VDR concentration, if VDR mRNA does not 
increase, this would imply a change in VDR probably at the post-
transcriptional level, rather than the transcriptional level. 
Although analogs and metabolites of vitamin D have been tested for 
their calcitropic activity, there are few reports of the effects of these 
compounds on gene expression (155). It was reported that a dose as high as 
800 ng of 1,25,28-trihydroxyvitamin D2 [1,25,28-D2] had no effects on rat 
intestinal calcium transport, but a dose as low as 250 ng upregulated 
intestinal CaBP mRNA (155). Whether the analogs of 1,25-D3, such as 
1,25,28-D2, regulate intestinal CaATPase mRNA has not been reported. No 
changes in plasma calcium have been observed in vitamin D-deficient rats 
injected with 7 ug of 1,25,28-02 per day for three months (Horst and 
Reinhardt, impublished). 
Calcium binding protein is the most extensively studied vitamin D-
dependent gene product. In mammals, CaBP-9K has a molecular size of 
approximately 9 kDa, is present in the intestine, and mouse kidney, whereas 
CaBP-28K has a molecular size of 28 kDa, is primarily found in the 
mammalian kidney, brain, pancreas and avian intestine(26). These proteins 
can be found in calcium-transporting tissues such as intestine, kidney, bones 
and some non-calcium transporting tissues such as brain and pancreas (38, 
69,76,137,141,156). Some of these l,25-D3-dependent calcium binding 
proteins are believed to stimulate intestinal calcium transport (54, 63, 97, 
120). 1,25-D3 markedly increases the vitamin D-dependent CaBPs and their 
mRNA in manmials, chick intestine, kidney and skin (54, 63, 77,102, 108, 
125). However, some observations are inconsistent with the theory of direct 
involvement of CaBP in calcium translocation. For example, a recent report 
indicated that in vitamin D-repleted rats, duodenal calcium transport was 
enhanced by a single injection of calcitriol, whereas CaBP-9K remained 
unchanged (25). Interestingly, some 1,25-D3 non-responsive organs such as 
heart and lung have significant levels of CaBPs and their mRNA (152, 153). 
No obligatory relationships have been found between 1,25-D3 effects and 
CaBP induction (152). Multiple factors such as calcium, phosphate, 
glucocorticoids, sex steroids and age are believed to participate in CaBP 
regulation (1, 20, 26, 54, 63, 90,102,143). For example, no active calcium 
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transport is reported in the intestine of newborn rats (39, 106), with 
undetectable levels of CaBP (106,144). Even large dose of 1,25-D3 cannot 
induce CaBP in newborn rats, but can induce both calcium transport and 
CaBP in older rats (13, 144). This is probably due to lack of receptors for 
1,25-D3 in the newborn rats (57) or possibly due to lack of response from 
undeveloped kidneys. Both the active transport of calcium and calcium 
binding protein levels reach a peak at about 30 days of age in rats, and then 
gradually decrease (106). A previous report has suggested that intestinal 
CaBP-9K mRNA was upregulated only in lactation and not in pregnancy 
(74). Bruns et al. (19) suggested that active transport in the duodenum 
increased during lactation. The enhanced calcium transport cannot be 
entirely explained by the increase in 1,25-D3 concentration, because Halloran 
and DeLuca (56) found significantly increased calcium transport ratio in 
vitamin D-deficient lactating rats that lacked detectable levels of circulating 
1,25-D3. a close relationship between 1,25-D3, intestinal CaBP and calcium 
transport has been observed in which the induction of CaBP coincides with 
increased calcium transport and this is induced by vitamin D, but not calcium 
(158, 159). The important functions of CaBPs include 1,25-D3-induced 
calcium transport and buffering of the intracellular calcium pool (15, 16, 
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63). Intestinal vitamin D-dependent calcium binding protein [CaBP-9K] was 
also reported to stimulate vesicular calcium transport (151). The structural 
analysis of CaBPs showed that CaBP-28K contains six highly conserved EF-
hand domains and binds 4 calcium per molecule, whereas CaBP-9K binds 2 
calcium per molecule and contains only 2 EF-hand domains (77, 80). The 
structures were initially described by Hunziker (69) as "loop-helix-loop 
structures that bind calcium to various oxygen-containing residues within the 
loop region". CaBPs may activate and bind to CaATPase (43, 44, 71, 96, 
119,151,157). However, some observations were inconsistent with the 
theory of direct involvement of vitamin D in calcium translocation (36, 49). 
Therefore, it is necessary to reevaluate the transcriptional regulation of 
CaBP-9K by 1,25-D3. 
Most of the initial work on the characterization, isolation, purification 
and reconstition of the plasma membrane calcium pump has been performed 
on the enzyme present in human red blood cells (128). Later, the enzyme 
was found in the plasma membrane of all other types of cells and was 
proposed as a ubiquitous enzyme (22). The CaATPase is a calcium pump 
which actually transports calcium out of the cytosol in order to maintain 
the concentration gradient of calcium across plasma membrane. The 
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typical CaATPase of the plasma membrane belongs to the P-type ATPase. 
A characteristic property of these enzymes is the formation of a covalently 
phosphorylated, obligatory intermediate; hence, the name P-type ATPase 
arises from the transfer of a phosphate of ATP to a specific aspartate residue 
at the catalytic site of the peptide (128). Recently a vitamin D-dependent 
plasma membrane calcium ATPase [PMCAl] gene has been cloned (126, 
145), making it possible to study calcium homeostasis more thoroughly. 
Schatzmann (22,124) first observed Ca2+-pump activity of the plasma 
membrane of red blood cells, and later Carafoli (22) reported that all 
eukaryotic cells studied have this enzymatic activity. Several authors 
proposed that plasma membrane CaATPase has 2 ATP-binding domains with 
different ATP affinity (97, 127). Although the mechanism is not clear, the 
higher affinity domain is suggested as the catalytic site; the lower one as a 
regulator (124). PMCA has a molecular weight of 130-140 kDa and 
transports one calcium per ATP. The calcium transport cycle is triggered 
by the ATP-dependent phosphorylation of an aspartyl residue, and the 
activity is augmented by the ATP-dependent phosphorylation of serine and 
threonine residues catalyzed by protein kinase A and C (163). At least four 
genes coding for plasma membrane CaATPases [PMCAl, PMCA2, PMCA3 
and PMCA4] have been found (24, 66). In rat cDNA libraries, all four 
isofonns of PMCA and their mRNA have been identified (53, 66, 126). 
PMCA4 was also discovered in human cells (130). The isoform variability 
of PMCAs appears to be generated by alternative splicing of single gene 
primary transcripts (53, 126, 128, 129). The reasons for the diversity of the 
enzyme are still a matter under investigation. Strehler (128) reported that 
highly conserved sequences are likely to represent domains essential for the 
basic catalytic and transport function and may also reflect specific constraints 
imposed on structural elements of the enzyme. In contrast, highly divergent 
sequences probably specify isoform-specific regulatory and functional 
specifications of the enzyme that are adapted to the physiological needs of the 
tissue in which the corresponding enzyme is expressed (128). PMCAl 
was found to be ubiquitous, whereas other isoforms were expressed in a 
tissue-dependent manner (53). In the duodenum, PMCAl is predominant 
and regulated by vitamin D (5, 21, 170). The other isoforms of CaATPase 
have not been reported to be regulated by vitamin D. In the intestine 1,25-
D3 enhances calcium transport, in part, by stimulating epithelial cell PMCAl 
mRNA and CaATPase activity (48, 75, 79, 87, 89, 91,170). An increase of 
CaATPase activity by 1,25-D3 has also been reported in cartilage cells (83) 
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and vascular smooth muscle cells (72) but not in circulating mononuclear 
cells (93). There seems to be a correlation between the cellular location and 
magnitude of activation of CaATPase, the sites and induction of calcium 
transport in intestine and kidney (54, 63). In rats, the calcium ATPase 
activity parallels the distribution of calcium absorption activity, with the 
highest activity in duodenum. This activity is reduced in vitamin D 
deficiency (48, 150). Calmodulin stimulates CaATPase to form a 
phosphorylated intermediate (146). This converts the enzyme into a high 
calcium affinity state in which the affinity for calcium increases 30-fold and 
the affinity for ATP increases 100-fold (121, 123). Phosphorylated 
metabolites of phosphatidylinositol have been found to be activators of 
CaATPase and phosphorylation by the cAMP-dependent protein kinase could 
also activate CaATPase (23). Phorbol esters and diacylglycerol are 
activators of calcium extrusion from intact cells (78,118). A rat placental 
CaATPase mRNA was shown to be upregulated during late pregnancy and 
early lactation (50). However, little is known of changes in rat intestinal 
CaATPase mRNA expression during late pregnancy and early lactation. The 
rate of calcium absorption in the aging rat decreases. This is partially due to 
decreased mRNA and protein synthesis, decreased activity of CaATPase and 
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CaBP, thus decreased ATP-dependent calcium uptake by basolateral 
membrane of enterocytes (5). 
It has been demonstrated that 1,25-D3 regulates PMCAl in rat and 
chick intestine (5, 21,170). However, several recent biochemical studies 
indicated that 1,25-D3 did not enhance the synthesis of intestinal PMCAl 
(134,138), and did not enhance ATP-dependent basolateral membrane 
calcium efflux (41). Therefore, it is important to re-evaluate gene 
regulation of CaATPase and CaBP by 1,25-D3. 
Calcium or phosphorus deficiencies have been reported to induce 
CaATPase gene expression and also to enhance calcium pump activity (21, 
162). This contradicted a report by Favus et al. (41) which indicated that 
ATP-dependent calcium uptake by isolated intestinal basolateral membrane 
vesicles was diminished when the vesicles were derived from rats fed a 
calcium-deficient diet. Whether calcium restriction or calcium itself induces 
upregulation of CaATPase and CaBP-9K mRNA is still a controversial 
subject, which apparentiy needs further studies. For example, the expression 
of CaBP-9K droppped after 24 hours in a calcium-free medium witii 
1 mM EGTA and an increase of media calcium concentration to 1.2 mM 
induced a 6- to 10-fold increase of CaBP-9K mRNA which can be blocked 
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by actinomycin D in duodenal cell culture (12). The increase of duodenal 
calcium transport in chicks by 1,25-D3 was found to be dependent on the 
presence of media calcium, since it was abolished by prior addition of EGTA 
and was restored upon addition of calcium (31). The reduced dietary 
calcium was reported to increase intestinal CaBP mRNA, but at the same 
time to diminish VDR mRNA despite increased circulating 1,25-D3 (93). 
No difference in the steady state of intestinal CaBP mRNA levels was found 
between rats fed low or normal calcium diet (136). In vitamin D-deficient 
status, dietary calcium manipulation did not affect either intestinal CaBP or 
its mRNA in chicks, but a single injection of 1,25-D3-induced equivalent 
duodenal CaBP and corresponding mRNA (55). However, earlier reports 
suggested that the adaptation to calcium-deficient diet was associated 
with an increased CaBP and its mRNA (6, 7, 42, 97, 105, 113, 133). 
In summary, whether transcriptional regulation of both CaATPase and 
CaBP are limiting factors in intestinal calcium transport and whether the 
adaptation to calcium and/or vitamin D deficiencies affects gene expression 
of intestinal CaATPase and CaBP, and which components of active transport 
system are activated during late pregnancy and early lactation, are still not 
well understood. The present investigation attempted to answer these 
22 
questions. 
References 
1. Abe, H., Amano, O., Yamakuni, T., Kuwano, R., Takahashi, 
Y. & Kendo, H. 1991. Transient expression of a calcium-binding protein 
(spot 35-calbindin) and its mRNA in the immature pituicytes of embryonic 
rats. Cell Tissue Res. 266:325-330. 
2. Adams, D. J., Barakeh, J., Laskey, R. and Van Breemen, C. 
1989. Ion channels and regulation of intracellular calcium in vascular 
endothelial cells. FASEB J. 3:2389-2400. 
3. Akerstrom, V. L. & Walters, M. R. 1992. Physiological effects of 
1,25-dihydroxyvitamin D3 in the TM4 Sertoli cell line. Am. J. Physiol. 
262:E884-E890. 
4. Antrobus, S. A., Hunziker, W. & Walters, M. R. 1990. 
Examination of interaction of calbindin-D28K with cytosolic proteins in the 
rat kidney and brain using the gel overlap technique. Int. Symp. calcium 
binding proteins. 7:168A. 
5. Armbrecht, H. J., Boltz, M. A. & Wongsurawat, N. 1994. 
Expression of plasma membrane calcium pump mRNA in rat intestine: effect 
of age and 1,25-dihydroxyvitamin D. Biochim. Biophys. Acta. 1195:110-
114. 
6. Bar, A. & Wasseman, R. H. 1973. Control of calcium absorption and 
intestinal calcium binding protein synthesis. Biochem. Biophys. Res. 
Commun. 54:191-196. 
7. Bar, A. & Hurwitz, S. 1979. The interaction between dietary calcium 
and gonadal hormones in their effect on plasma calcium, bone, 25-
hydroxycholecalciferol-1-hydroxylase, and duodenal calcium-binding 
protein, measured by a radioimmunoassay in chicks. Endocrinology. 
104:1455-1460. 
23 
8. Baerg, R. D., Kimberg, D. V. & Gershon, E. 1970. Effect of 
renal insufficiency on the active transport of calcium by the small intestine. 
J. Clin. Invest. 49:1288-1300. 
9. Bikle, D. D., Nemanic, M. K., Whitney, J. O. & Elias, P. W. 
1986. Neonatal human foreskin keratinocytes produce 1,25-
dihydroxyvitamin D3. Biochemistry. 25:1545-1548. 
10. Boass, A., Lovdal, J. A. & Toverud, S. U. 1992. Pregnancy- and 
lactation-induced changes in active intestinal calcium transport in rats. Am. 
J. Physiol. 262:G127-G134. 
11. Brasitus, T. A., Dudeja, P. K., Eby, B. & Lau, K. 1986. 
Correction by 1,25-dihydrocholecalciferol of enterocyte brush border 
membranes in vitamin D-deprived rats. J. Biol. Chem. 261: 16404-16409. 
12. Brehier, A. & Thomasset, M. 1990. Stimulation of calbindin-D9K 
(CaBP9K) gene expression by calcium and 1,25-dihydroxyvitamin D3 in 
fetal duodenal organ culture. Endocrinology. 127:580-587. 
13. Brenner, F., Lipton, J., Pansu, D., Buckley, M., singh, R., 
and Miller, A. 1982. Molecular and transport effects of 1,25-
dihydroxyvitamin D3 in rat duodenum. Fed. Proc. 41:61-65. 
14. Brenner, F. 1987. In: Physiology of the gastrointestinal tract (2nd 
ed.), edited by L. R. Johnson. New York: Raven, p 1419-1435. 
15. Brenner, F. & Stein, W. D. 1988. CaBPr faciliates intracellular 
diffusion for Ca pumping in distal convoluted tubule. Am. J. Physiol. 
255:F558-F562. 
16. Brenner, F. 1990. Transcellular calcium transport. In: Bronner F. 
(ed) intracellular calcium metabolism. Alan R. Liss, Inc., New York, p 415. 
17. Brenner, F. 1992. Current concepts of calcium absorption: An 
overview. J. Nutr. 122:641-643. 
24 
18. Brumbaugh, P. F. & Haussler, M. R. 1973. 1,25-
dihydroxyvitamin D3 receptor, competitive binding of vitamin D analogs. 
Life Sci. 13:1713-1746. 
19. Bruns, M. E., Boass & Tuverud, S. U. 1987. Regulation by 
dietary calcium of vitamin D-dependent calcium-binding protein and active 
calcium transport in the small intestine of lactating rats. Am. J. Endocrinol. 
121:278-283. 
20. Bruns, M. E., Overpeck, J. G., Smith, G. C., Hirsch, G. N., 
Mills, S. E. & Bruns, D. E. 1988. Vitamin D-dependent calcium binding 
protein in rat uterus: differential effects of estrogen, tamoxifen, 
progesterone, and pregnancy on accumulation and ceUular localization. 
Endocrinology. 122:2371-2378. 
21. Cai, Q., Chandler, J. S., Wasserman, R. H., Kumar, R., 
Penniston, J. T. 1993. Vitamin D and adaptation to dietary calcium and 
phosphate deficiencies increase the intestinal plasma membrane calcium 
pump gene expression. Proc. Natl. Acad. Sci. 90:1345-1349. 
22. Carafoli, E. 1987. Intracellular calcium homeostasis. Annu. Rev. 
Biochem. 56:395-433. 
23. Carafoli, E. 1988. Membrane transport of calcium: an overview. 
Methods Enzymol. 157:3-11. 
24. Carafoli, E. 1992. The Ca2+ pump of plasma membrane. J. Biol. 
Chem. 267:2115-2118. 
25. Chabanis, S., Hanrotel, C., Duchambon, P., Banide, H., 
Kubrusly, M., Aymard, P., Lacour, B. & Drueke, T. 1994. 
Duodenal calcium binding protein and active transport in rats: are they 
functionally related? Nephrol. Dial. Transplant. 9:1402-1407. 
26. Christakos, S., Gabrielides, C. & Rhoten W. B. 1989. Vitamin 
D-dependent calcium binding proteins: chemistry, distribution, functional 
considerations, and molecular biology. Endocrine Rev. 10:3-16. 
25 
27. Costa, E. M., Hirst, M. A. & Feldman, D. 1985. Regulation of 
1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured 
mammalian cells. Endocrinology. 117:2203-2210. 
28. Darwish, H. M., Burmester, J. K., Moss, V. & DeLuca 1993. 
Transcriptional activity by the 1,25-dihydroxyvitamin D3 receptor is 
mediated by phophorylation. Biochim Biophys. Acta. 1167:29-36. 
29. deBoland, A. R. & Norman, A. W. 1990. Evidence for 
involvement of protein kinase C and cyclic adenosine 3',5' monophosphate-
dependent protein kinase in the 1,25-dihydroxyvitamin D3-mediated rapid 
stimulation of intestinal calcium transport (transcaltachia). Endocrinology. 
127:39-45. 
30. Dame, M. C., Pierce, E. A. & DeLuca, H. F. 1985. Identification 
of the porcine intestinal 1,25-dihydroxyvitamin D3 receptor on sodium 
dodecyl sulphate/polyacryamide gels by renaturation and immunoblotting. 
Proc. Natl. Acad. Sci. USA 82:7825-7829. 
31. deBoland, A. R. & Norman, A. W. 1990. Influx of extracellular 
calcium mediates 1,25-dihydroxyvitamin D3-dependent transcaltachia (the 
rapid stimulation of duodenal Ca2+ transport). Endocrinology. 127:2475-
2480. 
32. deBoland, A. R., Nemere, I. & Norman, A. W. 1990. Ca2+ 
charmel agonist bay K8644 mimics 1,25-dihydroxyvitamin D3 rapid 
enhancement of Ca2+ transport in chick perfused duodenum. Biochem. 
Biophys. Res. Commun. 166:217-222. 
33. de Boland, A. R. & Norma, A. W. 1990. Evidence for 
involvement of protein kinase C and cyclic adenosine 3',5' monophosphate-
dependent protein kinase in the 1,25-dihydroxyvitamin D3-mediated rapid 
stimulation of intestinal calcium transport (Transcaltachia). Endocrinology. 
127:39-45. 
34. DeLuca, H. F. 1988. The vitamin story: a collaborative effort of basic 
science and clinical medicine. FASEB J. 2:224-236. 
26 
35. Deluca, H. F., Krisinger, J. & Darwish, H. 1990. The vitamin D 
system: 1990 Kidney Int. 38:S2-S8. 
36. Donahue, H. J., Borke, J. L., Penniston, J. T. & Kumar, R. 
1988. Effect of purified 28-KDa calcium binding protein (CaBP) on 
calmodulin-stimulated human erythrocyte (Ca2+-Mg2+) ATPase kinetics. J. 
Bone Mineral Res. 3:S51. 
37. Dostal, L. A. & Toverud, S. U. 1984. Effect of vitamin D on 
duodanal calcium absorption in vivo during development. Am. J. Physiol. 
246:G528-G534. 
38. Desplan, C., Thomasset, M. & Moukhtar, M. 1983. Synthesis, 
molecular cloning, and restriction analysis of DNA complementary to 
vitamin D-dependent calcium-binding protein mRNA from rat duodenum. 
258: 2762-2765. 
39. Dostal, L. A. & Toverud, S. U. 1984. Effect of vitamin D3 on 
duodenal calcium absorption in vivo during early development. Am. J. 
Physiol. 246:G528-G534. 
40. Favus, M. J., Mangelsdorf, D. J., Tembe, V., Coe, B. J. & 
Haussler, M. R. 1988. Evidence for in vivo upregualtion of the intestinal 
vitamin D receptor during dietary calcium restriction in the rat. J. Clin. 
Invest. 82:218-224. 
41. Favus, M. J., Tenbe, V., Ambrosic, K. A. & Nellans, H. N. 
1989. Effects of 1,25-dihydroxyvitamin D3 on enterocyte basolateral 
membrane calcium transport in rats. Am. J. Physiol. 256:G613-G617. 
42. Fox, J., Pickard, D. W., Care, A. D. & Murray, T. M. 1978. 
Effect of low phosphorus diet on intestinal calcium absorption and the 
concentration of calcium-binding protein in intact and parathyroidectomized 
pigs. Endocrinology. 78:379-387. 
43. Freund, T. S. 1982. In Norman, A. W., Schaefer, K., Herrath, Dv. & 
Grigoleit, H. G. (eds) Vitamin D: chemical, biochemical and clinical 
endocrinology of calcium metabolism. Walter de Gruyter, Berlin, p 249. 
27 
44. Freund, T. S. & Christakos, S. 1985. Enzyme modification by 
renal calcium binding proteins. In Norman, A. W., Schaefer, K., Grigoleit, 
H. G. & Herrath, D. V. (eds) Vitamin D. A chemical, biochemical and 
clinical update. Walter de Gruyter & Co., Berlin, p 369. 
45. Gallagher, J. C., Riggs, B. L. & Deluca, H. F. 1980. Effect of 
estrogen on calcium absorption and serum vitamin D metabolites in 
postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 51:1359-1364. 
46. Garabedian, M., Tanaka, Y., Holick, M. F. 1974. Response of 
intestinal calcium transport and bone calcium mobilization to 1,25-
dihydroxyvitamin D3 in thyroparathyroidectomized rats. Endocrinology. 
94:1022-1027. 
47. Gertner, J. M., Coustan, D. R., Kllger, A. S., Mallette, L. 
E., Ravin, N. & Broadus, A. E. 1986. Pregnancy as state of physiologic 
absoiptive hypercalciuria. Am. J. Med. 81:451-456. 
48. Ghijsen, W. E. & Van Os C. H. 1982. 1,25-dihydroxyvitamin D3 
regulates ATP-dependent calcium transport in basolateral plasma membranes 
of rat enterocytes. Biochim. Biophy. Acta. 689:170-172. 
49. Ghijsen, W. E., Van Os C. H., Heizmann, C. W. & Murer, H. 
1986. Regulation of duodenal Ca2+ pump by calmodulin and vitamin D-
dependent Ca2+-binding protein. Am. J. Physiol. 251:G223-G229. 
50. Glazier, J. D., Atkinson, D. E., Thornburg, K. L., Sharpe, P. 
T., Edwards, D., Boyd, R. D. H. & Sibley, C. P. 1992. Gestational 
changes in Ca2+ transport across rat placenta and mRNA for calbindin-9K 
and Ca(2+)-ATPase. Am. J. Physiol. 262:R930-R935. 
51. Goodman, D. B. P., Haussler, M. R. & Rasmussen, H. 1972. 
Vitamin D3 induced alteration of microvillar membrane lipid composition. 
Biochem, Biophys. Res. Commun. 46:80-86. 
52. Gray, T. K., Lester, G. E. & Lorene, R. S. 1979. Evidence for 
extrarenal 1-hydroxylation of 25-hydroxyvitamin Dsin pregnancy. Science. 
204:1311-1313. 
28 
53. Greeb, J. and Shull, G. E. 1989. Molecular cloning of a third 
isoform of the calmodulin-sensitive plasma membrane Ca2+ transporting 
ATPase that is expressed predominantly in brain and skeletal muscle. J. Biol. 
Chem. 264:18569-18576. 
54. Gross, M. & Kumar, R. 1990. Physiology and biochemistry of 
vitamin D-dependent calcium binding proteins. Am. J. Physiol. 259:F195-
F209. 
55. Hall, A. K. & Norman, A. W. 1990. Regulation of calbindin-D28K 
gene expression in the chick intestine: effects of serum calcium status and 
1,25-dihydroxyvitamin D3. J. Bone Miner. Res. 5:331-336. 
56. Halloran, B. P. & DeLuca, H. F. 1980. Calcium transport in small 
intestine during pregnancy and lactation. Am. J. Physiol. 239:E64-E68. 
57. Halloran, B. P. & DeLuca, H. F. 1981. Appearance of the 
intestinal cytosolic receptor for 1,25-dihydroxyvitamin D3 during neonatal 
development of the rat. J. Biol. Chem. 256:7338-7342. 
58. Hannah, S. S. & Norman, A. W. 1994. l,25-(OH)2 vitamin Da-
regulated expression of eukaryotic genome. Nutr. Rev. 52:376-382. 
59. Haussler, M. R., Donaldson, C. A. & Kelly, M. A. et al 1985. 
Function and mechanism of action of the 1,25-dihydroxyvitamin D3 
receptor. In Norman, A. W., Schaefer, K., Grigoleit, H-G, von Herrath, D. 
(eds): Vitamin D: Chemicla, biochemical and clinical update. Berlin, Walter 
de Gruyter, p 83-92. 
60. Haussler, M. R. 1986. Vitamin D receptors: nature and function. 
Aimu. Rev. Nutr. 6:527-562. 
61. Haussler, M. R., Mangelsdorf, D. J., Komm, B. S., 
Terpening, C. M., Yamaoks, K., Allegretto, E. A., Baker, A. R., 
Shine, J., McDonnell, D. P., Hughes, M., Weigel, N. L., 
O'Malley, B. W. & Pike, J. W. 1988. Molecular biology of the vitamin 
D hormone. Recent Prog. Horm. Res. 44:263-305. 
29 
62. Heaney, R. P. & Skillman, T, G. 1971. Calcium metabolism in 
nonnal human pregnancy. J. Clin. Endocrinol. Metab. 33:661-669. 
63. Heimann, C. W. & Hunziker, H. 1990. Intracellular calcium-
binding molecules. In: Bronner F (ed) Intracellular calcium regulation. 
Alan. R. Liss, Inc., New York, p 211. 
64. Horiuchi, N., Suda, T., Takahashi, H., Shimazawa, E. & 
Ogata, E. 1977. In vivo evidence for the intermediary role of 3',5'-cyclic 
AMP in parathyroid hormone-induced 1, 25-dihydroxyvitamin D3 synthesis 
in rats. Endocrinology. 101:969-974. 
65. Howard, A., Legon, S., and Walters, J. R. F. 1992. Plasma 
membrane calcium pump expression in human placenta and small intestine. 
Biochem. Biophys. Res. Commun. 183:499-505. 
66. Howard, A., Legon, S. & Walters, J. F. 1993. Human and rat 
intestinal plasma membrane calcium pump isoforms. Am. J. Physiol. G917-
G925. 
67. Howard, G. A., Turner, R. T., Sherrard, D. J. & Bayllnk, D. 
J. 1981. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 
1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J. Biol. Chem. 
256;7738-7740. 
68. Huang, Y. C., Lee, S., Stolz, R. & Gabrielides, C. 1989. Effect 
of hormone and development on the expression of die rat 1,25-
dihydroxyvitamin D3 receptor gene. Comparison with calbindin gene 
expression. 264:17454-17461. 
69. Hunziker, W. 1986. The 28-kDa vitamin D-dependent calcium-
binding protein has a six domain structure. Proc. Natl. Acad. Sci. USA 
83:7578-7582. 
70. Inoue, T. & Kawashima H. 1988. 1,25-dihydroxyvitamin D3 
stimulates 45Ca2+-uptake by cultured vascular smooth muscle cells derived 
from rat aorta. Biochem. Biophys. Res. Commun. 152:1388-1394. 
30 
71. James, P. Vorherr, T., Thulin, E., Forsen, S. & Carafoli, E. 
1991. Identification and primary structure of a calbindin 9K binding domain 
in the plasma membrane Ca2+ pump. FEBS Lett 278:155-159. 
72. Kawashima, H. 1988. 1,25-dihydroxyvitamin D3 stimulates Ca-
ATPase in a vascular smooth muscle cell line. Biochem .Biophys. Res. 
Commun. 150:1138-1143. 
73. Kostial K., Gruden, N. & Durakovic, A. 1969. Intestinal 
absorption of 47calcium and ^^strontium in lactating rats. Calcif. Tissue Res. 
4:113-119. 
74. Krisinger, J., Dann, J. L., Jeung, E. B. & Leung, P. C. K. 
1992. Calbindin-D9K gene expression during pregnancy and lactation in die 
rat. Mol. and Cell. Endocrinol. 88:119-128. 
75. Kumar, R. 1986. The metabolism and mechanism of action of 1,25-
dihydroxyvitamin D3. Kid. Int. 30:793-803. 
76. Kumar, R., Wieben, E. & Beecher, S. J. 1989. The molecular 
cloning of the complementary deoxyribonucleic acid for bovine vitamin D-
dependent calcium-binding protein: structure of the full length protein and 
evidence for homologies with other calcium-binding proteins of the 
troponin-C superfamily of proteins. Mol. Endocrinol. 3:427-432. 
77. Kumar, R. 1991. Vitamin D and calcium transport. Kid. Int. 40:1177-
1189. 
78. Lagast, H., Lew, P. D. & Waldvogel, F. A. 1984. Adenosine 
triphosphate-dependent calcium pump in the plasma membrane of guinea pig 
and human neotrophils. J. Clin. Invest. 73:107-115. 
79. Lane, S. M. & Lawson, D. E. M. 1978. Differentiation of the 
changes in alkaline phosphatase from calcium ion-activated adenosine 
triphosphatase activities associated with increased calcium absorption in 
chick intestine. Biochem. J. 174:1067-1070 . 
31 
80. Leathers, V. L., Linse, S., Forsn S. & Norman , A. W. 1990. 
Calbindin-D28K, a 1,25-dihydroxyvitamin D3-induced calcium-binding 
protein, binds five or six Ca2+ ions with high affinity. J. Biol. Chem. 
265:9838-9841. 
81. Lee, Y., Inaba, M., DeLuca, H. F. & Melon, W. S. 1989. 
Immunological identification of 1,25-dihydroxyvitamin D3 receptors in 
human promyelocytic leukemic cells (HL-60) during homologous regulation. 
J. Biol. Chem. 264:13701-13705. 
82. Lee, D. B. N., Hardwick, L. L, Hu, M. S. and Jamgotchian, 
N. 1990. Vitamin D~independent regulation of calcium and phosphate 
absorption. Miner. Electr. Metab. 16:167-173. 
83. Lidor, C. & Edelstein, S. 1987. Calcitriol increases Ca2+-ATPase 
activity. Biochem. Biophys. Res. Commun. 144:713-717. 
84. Lobaugh, B., Boass, A., Lester, G. E. & Toverud, S. U. 1990. 
Regulation of serum 1,25-dihydroxyvitamin D3 in lactating rats. Am. J. 
Physiol. 259:E665-671. 
85. Lund, B. & Seines, A. 1979. Plasma 1,25-dihydroxyvitamin D levels 
in pregnancy and lactation. Acta. Endocrinol. 92:330-335. 
86. Mahoney, A. W., Holbrook, B. S. & Hendrick, D. G. 1975. 
Effects of calcium solubility or absorption by rats with induced 
achlorhydria. Nutr. Metab. 18:310-317. 
87. Mangelsdorf, D. J., Pike, J. W. & Haussler, M. R. 1987. Avian 
and mammalian receptors for 1,25-dihydroxyvitamin D3: in vitro translation 
to characterize size and hormone dependent regulation. Proc. Natl. Acad. 
Sci. USA 84:354-358. 
88. Martin, D. L., Melancon, M. J. & Deluca, H. F. 1969. Vitamin 
D stimulated, calcium-dependent adenosine triphosphatase from brush 
borders of rat small intestine. Biochem. Biophys. Res. Commun. 35:819-
823. 
32 
89. Marx, S. J., Liberman, U. A. & Eil, C. 1983. Calciferols: actions 
and deficiencies of action. Vitam. Horm. 40:235-308. 
90. Mathieu, C. L., Burnett, S. H., Mills S. E., Overpeck, J. G., 
Bruns, D. E. & Bruns, M. E. 1989. Gestational changes in calbindin-
D9K in rat uterus, yolk sac, and placenta: implications for matemal-fetal 
calcium transport and uterine muscle function. Proc. Natl. Acad. Sci. USA 
86:3433-3437. 
91. McDonnell, D. P., Mangelsdorf, D. J., Pike, J. W., Haussler, 
M. R. & O'Malley, B. W. 1987. Molecular cloning of complementary 
DNA encoding the avian receptor for vitamin D. Science. 235:1214-1217. 
92. Melancon, M. J. & DeLuca, H. F. 1970. Vitamin D stimulation of 
calcium-dependent adenosine triphosphatase in chick intestinal brush 
borders. Biochemistry. 9:1658-1664. 
93. Meyer, J., Fullmer, C. S., Wasserman, R. H., Komm, B. S. & 
Haussler, M. R. 1992. Dietary restriction of calcium, phosphorus and 
vitamin D elicits differential regulation of the mRNAs for avian intestinal 
calbindin-D28K and the 1,25-dihydroxyvitamin D receptor. J. Bone Miner. 
Res. 7:441-448. 
94. Minghetti, P. P. & Norman, A. W. 1988. 1,25-dihydroxyvitamin 
D3 receptors: gene regulation and genetic circuitry. FASEB J. 2:3043-3053. 
95. Morgan, D. W., Welton, A. F., Heick, A. E. & Christakos, S. 
1986. Specific in vitro activation of Ca,Mg-ATPase by vitamin-dependent rat 
renal calcium binding protein (calbindin D28K). Biochem. Biophys. Res. 
Commun. 138:547-553. 
96. Morimoto, S., Birge, S. J., Shen, V. Avioli, L. V. 1985. (Ca2+ 
+ Mg2+)-ATPase activity in plasma membrane of circulating mononuclear 
cells. Lack of direct effect of vitamin D. J. Biol. Chem. 260:14953-14957. 
33 
97. Morrissey, R. L. & Wasserman, R. H. 1971. Calcium absorption 
and calcium-binding protein in chicks on different calcium and phosphate 
intakes. Am. J. Physiol. 220:1509-1515. 
98. Muallen, S. & Karlish, S. J. 1980. Regulatory interaction between 
calmodulin and ATP on the red cell Ca2+ pump. Biochim. Biophys. Acta. 
597:631-636. 
99. Nellans, H. N. & Popovitch, J. R. 1984. Role of sodium in 
intestinal calcium transport. In: Epithelial calcium and phosphate transport: 
molecular and cellular aspects. (Bronner, F. & Peterlik M. eds), p 301-306, 
AlanR. Liss, New York, NY. 
100. Nemere, I. & Norman, A. W. 1990. Transcaltachia, vesicular 
calcium transport, and microtubule-associated calbindin-D28K: Emerging 
views of 1,25-dihydroxyvitamin Ds-mediated intestinal calcium absorption. 
Mineral and Electro. Metabolism 16:109-114. 
101. Nemere, I. & Norman, A. W. 1991. Steroid hormone actions at 
the plasma membrane: induced calcium uptake and exocytotic events. Mol. 
Cell Endocrinol. 80:C165-C169. 
102. Norman, A. W., Roth, J. & Orel, L. 1982. The vitamin D 
endocrine system: steroid metabolism, hormone receptors and biological 
response (calcium binding protein). Endocr. Rev. 3:331-366. 
103. Ozono, K., Sone, T. & Pike, J. W. 1991. The genomic 
mechanism of action of 1,25-dihydroxyvitamin D3. J. Bone Mineral Res. 
6:1021-1027. 
104. Pan, L. C. & Price, P. A. 1987. Ligand-dependent regulation of 
the 1,25-dihydroxyvitamin D3 receptor in rat osteosarcoma cells. J. Biol. 
Chem. 262:4670-4675. 
105. Pansu, D., Ballaton, C. & Bronner F. 1981. Effect of Ca intake 
on saturable and nonsaturable components of duodenal Ca transport. Am. J. 
Physiol. G32-G37. 
34 
106. Pansu, D., Bellaton., C. & Bronner, F. 1983. Developmental 
changes in the mechanisms of duodenal calcium transport in the rat. Am. J. 
Physiol. 244:G20-G26. 
107. Pansu, D., Bellaton, C., Roche, C. & Brenner, F. 1983. 
Duodenal and ileal calcium absorption in the ratard effects of vitamin D. 
Am. J. Physiol. 244:G695-G700. 
108. Pavlovitch, J. H., Didierjean, L., Rizk, M., Balsan, S. & 
Saurat, J. H. 1983. Skin calcium-binding protein: distribution in other 
tissues. Am. J. Physiol. 244:C50-C57. 
109. Pike, J. W. 1985. Intracellular receptors mediate the biological 
action of 1,25-dihydroxyvitamin D3. Nutr. Rev. 43:161-168. 
110. Pike, J. W. 1985. New insights into mediators of vitamin D3 action, 
in vitamin D: Chemiclal, biological and clinical update. Norman, A. W., 
Schaefer, K., Grigoleit, H-G. & von Herrath, D., Eds., Walter de Gruyter, 
Berlin, p 97. 
111. Pike, J. W. 1991. Vitamin D3 receptors: Structure and function in 
transcription. Annu. Rev. Nutr. 11:189-216. 
112. Pietrobon, D., Divirgilio, F. & Pozzan, T. 1990. Structural and 
functional aspects of calcium homeostsis in eukaryotic cells. Eur. J. 
Biochem. 193:599-622. 
113. Rader, J. I., Baylink, D. J., Hughes, M., Safilian, E. F. & 
Haussler, M. R. 1979. Calcium and phophoms deficiency in rats: effects 
on PTH and 1,25-dihydroxyvitamin D3. Am. J. Physiol. 236:E118-E122. 
114. Rasmussen, H., Matsumoto, T., Fontaine, O. & Goodman, D. 
B. P. 1982. Role of changes in membrane lipid structure in the action of 
1,25-dihydroxyvitamin D3. Fed. Proc. 41:72-77. 
115. Reichel, H., Koeffler, H. P. & Barbers, R. et al 1985. 1,25-
dihydroxyvitamm D3 and the hematopoietic system. In Norman, A. W., 
35 
Schaefer, K., Grigoleit, H-G. & von Herrath, D. (eds); vitamin D: chemical, 
biological & clinical update. Berlin, Walter de Gruyter, pp 167-176. 
116. Reichel, H., Koeffler, H. P. & Norman, A. W. 1989. The role 
of vitamin D endocrine system in health and disease. N. Engl. J. Med. 
320:980-991. 
117. Reinhold, J. G., Faradji, B., Abadi, P. & Ismail-Beigi. F. 
1976. Decreased absorption of calcium, magnesium, zinc and phosphorus by 
human due to increased fiber and phosphoms consumption as wheat bread. J. 
Nutr. 106:493-503. 
118. Rickard, J. E. & Sheterline, P. 1987. Evidence that phorbol ester 
interferes with stimulated Ca2+ redistribution by activating Ca2+ efflux in 
neutrophil leucocytes. Biochem. J. 231, 623-628. 
119. Reisner, P. D.c Christakos, S. & Vanaman, T. C. 1992. In 
vitro enzyme activation with calbitidin-D28K, the vitamin D-dependent 28 
kDa calcium binding protein. FEBS Lett. 297:127-131. 
120. Roche, C., Bellaton, C., Pansu, D., Miller, A., & Brenner, 
F. 1986. Localization of vitamin D-dependent active calcium transport and 
relationship to CaBP. Am. J. Physiol. 251:G314-G320. 
121. Rossi, J. P., Rega, A. F. & Garrahan, P. J. 1985. Compound 
48/80 and calmodulin modify the interaction of ATP with the (Ca2++Mg2+)-
ATPase of red cell membranes. Biochim. Biophys. Acta. 816:379-386. 
122. Schacter, D., Dowdle, E. & Schenker, H. 1960. Active transport 
of calcium by die small intestine of the rats. Am. J. Physiol. 198:263-268. 
123. Scharff, O. & Foder, B. 1982. Rate constants for calmodulin 
binding to Ca2+-ATPase in erythrocyte membranes. Biochim. Biophys. Acta. 
691:133-143. 
124. Schatzmann, H. J. 1989. The calcium pump of the surface 
membrane and the sarcoplasmic reticulum. Annu. Rev. Physiol. 51:473-485. 
36 
125. Schelling, C. P., Didierjean L., Rizk, M., Pavlovitch, J. H., 
Takagi, T. & Heizmann, C. W. 1987. Calcium-binding proteins in rat 
skin. FEBS Lett. 214:21-27. 
126. Shull, G. E. & Greeb, J. 1988. Molecular cloning of two isoforms 
of the plasma membrane Ca2+-transporting ATPase from rat brain. J. Biol. 
Chem. 263:8646-8657. 
127. Stieger, J. & Luterbacher, S. 1981. Some properties of purified 
(Ca2++Mg2+)-ATPase from human red cell membranes. Biochim. Biophys. 
Acta. 641:270-275. 
128. Strehler, E. (1991) Recent advances in the molecular 
characterization of plasma membrane Ca2+ pumps. J. Membr. Biol. 1991. 
120:1-15. 
129. Strehler, E. E., Strhler-Page, M. A., Vogel, G. & Carafoli, 
E. 1989. mRNAs for plasma membrane calcium pump isoforms differing in 
their regulatory domain are generated by altemative splicing that involves 
two intemal donor sites in a single exon. Proc. Natl. Acad. Sci. USA 
86:6908-6912. 
130. Strehler, E. E., James, P., Fischer, R., Heim, R., Vorherr, 
T., Filoteo, A. G., Penniston, J. T. & Carafoli, E. 1990. Peptide 
sequence analysis and molecular cloning reveal two calcium pump isoforms 
in the human erythrocyte membrane. J. Biol. Chem. 265:2835-2842. 
131. Strom, M., Sandgren, M. E., Brown T. A. & DeLuca, H. F. 
1989. 1,25-dihydroxyvitamin D3 upregulates the 1,25-dihydroxyvitamin D3 
receptor in vivo. Proc. Natl. Acad. Sci. USA 86:9770-9773. 
132. Surago, S., Horiuchi, N. & Takahashi, N. 1979. The site of 
1,25-dihydroxyvitamin D3 production in pregnancy. Biochem. Biophys. Res. 
Commun. 90:948-955. 
133. Swaminathan, R., Sommerville, B. A. & Care, A. D. 1977. 
The effect of dietary calcium on the activity of 25-hydroxycholecalciferol-l-
37 
hydroxylase and Ca absorption in vitamin D-replete chicks, Br. J. Nutr. 38, 
47-54. 
134. Takito, J., Shinki, T., Tanaka, H. & Suda, T. 1992. Mechanism 
of regulation of calcium pumping activity in chick intestine. Am. J. Physiol. 
262:G797-G805. 
135. Tanaka, Y., Halloran, B., Schnoes, H. K. & Deluca, H. F. 
1979. In vitro production of 1,25-dihydroxyvitamin D3 by rat placental 
tissue. Proc. Natl. Acad. Sci. USA 76:5033-5035. 
136. Theofan, G., King, M. W., Hall, A. K. & Norman, A. W. 
1987. Expression of calbindin-D28K mRNA as a function of altered serum 
calcium and phosphorus levels in vitamin D-replete chick intestine. Mol. Cell 
Endocrinol. 54:135-140. 
137. Thomasset, M., Parkes, C. O. & Cuisinier-Gleizes, P. 1982. 
Rat calcium binding proteins: distribution, development, and vitamin D 
dependence. Am. J. Physiol. 243:E483-E488. 
138. Timmermans, J. A., Kaune, R., Bindels, R. J. & van Os C. 
H. 1991. Quantification of Ca(2+)-ATPases in porcine duodenum. Effect of 
I,25-dihydroxyvitamin D3 deficiency. Biochim. Biophys. Acta. 1065:177-
184. 
139. Tornquist, K. & Tashjian, A. H. 1989. Dual actions of 1,25 
dihydroxycholecalciferol on intracellular Ca2+ in GH4C1 cells: evidence for 
effects on voltage-operated Ca2+ channels and Na+/Ca2+ exchanger. 
Endocrinology. 124:2765-2776. 
140. Toverud, S. U., Boass, A., Haussler, M. R. & Pike, J. W. 
1983. Circulating levels and function of 1,25-dihydroxyvitamin 63 in 
lactation. J. Steroid Biochem. 19:505-510. 
141. Tsarbopoulos, A., Gross, M., Kumar, R. & Jardine, I. 1989. 
Rapid identification of calbindin-D28K cyanogenbromide peptide fragments 
by plasma absorption mass spectrometry. Biomed. Environ. Mass Spectrom. 
18:387-393. 
38 
142. Tucker, G. Ill, Gagnon, R. E. & Haussler M. R. 1973. 
Vitamin D3-25-hydroxylase. Tissue occurence and apparent lack of 
regulation. Arch. Biochem. Biophys. 155:47-57. 
143. Varghese, S., Lee, S., Huang, Y-C & Christakos, S. 1988. 
Analysis of rat vitamin D-dependent calbindin-D28K gene expression. J. 
Biol. Chem. 263:9776-9784. 
144. Ueng, T. H., Golub, E. E. & Bronner, F. 1979. The effect of 
age and 1,25-dihydroxyvitamin D3 treatment on the intestinal calcium-
binding protein of suckling rats. Arch. Biochem. Biophys. 196:624-630. 
145. Verma, A. K., Filoteo, A. G., Stanford, D. R., Wieben, E. 
D., Penniston, J. T., Strehler, E. E., Fischer, R., Heim, R., 
Vogel, G., Mathew, Strehler-Page M. A., James, P., Vorherr, T., 
Krebs, J. & Carafoli, E. 1988. Complete primary structure of a human 
plasma membrane Ca2+ pump. J. Biol. Chem. 263:14152-14159. 
146. Wajsman, R., Walters, J. R. F. & Weiser, M. M. 1988. 
Identification and isolation of the phosphorylated intermediate of the calcium 
pump in rat enterocyte basolateral membranes, biochem. J. 256:593-598. 
147. Walters M. R., Hunziker, W., Norman, A. W. 1980. 
Unoccupied 1,25-dihydroxyvitamin D3 receptors; nuclear/cytosol ratio 
depends on ionic strength. J. Biol. Chem. 255:6799-6805. 
148. Walters, M. R. 1985. Steroid hormone receptors and the nucleus. 
Endocr. Rev. 6:512-543. 
149. Walters, M. R., Ilenchuk, T. T. & Claycomb, W. C. 1987. 
1,25-dihydroxyvitamin D3 stimulates Ca2+ uptake by cultured adult rat 
ventricular cardiac muscle cells. J. Biol. Chem. 262:2536-2541. 
150. Walters, J. R. F. & Weiser, M. M. 1987. Calcium transport by 
rat duodenal villus and crypt basolateral membranes. Am. J. Physiol. 
252:0170-0177. 
39 
151. Walters, J. R. F. 1989. Calbindin-D9K stimulate calcium pump in 
rat enterocyte basolateral membranes. Am. J. Physiol. 256;G124-G128. 
152. Walters, M. R., Bruns, M. E., Carter, R. M. & Riggle, P. C. 
1991. Vitamin D-independence of small calcium binding proteins in 
nonclassical target tissues. Am. J. Physiol. 260:E794-E800. 
153. Walters, M. R. & Hunziker, W. 1991. Northern and PGR analysis 
of CaBP-D28K Expression. In Norman, A. W., Bouilon, R. & Thomasset, 
M. (eds) Vitamin D: gene regulation, structure-function analysis and clinical 
applications. Walter de Gruyter & Co., New York, p 619. 
154. Walters, M. R. 1992. Newly identified actions of the vitamin D 
endocrine system. Endocrine Reviews. 13:719-764. 
155. Wang, Y. Z., Li, H., Bruns, M. E., Uskokovic, M., Trultt, 
G. A., Horst, R., Reinhardt, T. & Christakos, S. 1993. Effect of 
1,25,28-trihydroxyvitamin D2 and 1,24,25-trihydroxyvitamin D3 on 
intestinal calbindin-D9K mRNA and protein: is there a correlation with 
intestinal calcium transport? J. Bone Miner. Res. 8:1483-1490. 
156. Wasserman, R. H., Corradlnoj R. A. & Taylor, A. N. 1968. 
Vitamin D-dependent calcium-binding protein. Purification and some 
properties. J. Biol. Chem. 243:3978-3986. 
157. Wasserman, R. H. 1980. In: Siegel, F. L., Carofili, E., Kretsinger, 
R. H., Malennan, D. H. & Wasserman, R. H. (eds) Calcium binding protein: 
structure and function. Elsevier-North Holland, Inc., New York, p 357. 
158. Wasserman, R. H. 1981. Intestinal absorption of calcium and 
phosphorus. Fed. Proc. 40:68-72. 
159. Wasserman, R. H., Fullmer, C. S. & Shimura, F. 1984. 
Calcium absorption and the molecular effects of vitamin D3, in Vitamin D: 
basic and clinical aspects, edited by Kumar, R., Boston, Martinus Nijhoff. p 
233-302. 
40 
160. Wasserman, R. T. 1988. Cellular calcium and phosphate transport 
in health and disease, p 3-13, Alan R. Liss, Inc. 
161. Wasserman, R. H., Chandler, J. S., Meyer, S. A.,. Smith, C. 
A., Brindak, M. E., Fullmer, C. S., Penniston, J. T. & Kumer, R. 
1992. Intestinal calcium transport and calcium extrusion processes at 
basolateral membrane. J. Nutr. 122:662-671. 
162. Wasserman, R. H., Smith, C. A., Brindak, M. E., Talamoni, 
N., Fullmer, C. S., Pennison, J. T. & Kumar, R. 1992. Vitamin D 
and mineral deficiencies increase the plasma membrane calcium of chick 
intestine. Gastroenterology. 102:886-894. 
163. Wasserman, R. H. & Fullmer, C. S. 1995. Vitamin D and 
intestinal calcium transport: Facts, speculations and hypotheses. J. Nutr. 
125:1971S-1979S. 
164. Weisman, Y., Vargas, A., Duckett, G. 1978. Synthesis of 1,25-
dihydroxyvitamin D in the nephrectomized pregnant rats. Endocrinology. 
103:1992-1996. 
165. Weisman, Y., Harell, A. & Edelstein, S. 1979. 1,25-
dihydroxyvitamin D3 and 24,24-dihydroxyvitamin D3 in vitro synthesis by 
human decidua and placenta. Nature. 281:317-319. 
166. Whitsett, J. A., Ho, M. & Tsang, R. C. 1981. Synthesis of 1,25-
Dihydroxyvitamin D3 by human placenta in vitro. J. Clin. Endocrinol. 
Metab. 53:484-488. 
167. Max, E. E., Goodman, D. B. P. & Rasmussen, H. 1978. 
Purification and characterization of chick intestine brush border membrane; 
effects of 1-hydroxyvitamin D3 treatment. Biochim. Biophys. Acta. 511:224-
239. 
168. Xue, H., McCarron, D. A. & Bukoski, R. D. 1991. Vitamin D3-
induced 45Ca2+ uptake in vascular myocytes from spontaneously 
hypertensive and normotensive rats. Life Sci. 49:651-659. 
41 
169. Yamamoto, M. & Kawanobe, Y. 1984. Vitamin D deficiency and 
renal calcium transport in the rat. J. Clin. Invest. 74:507-513. 
170. Zelinski, J. M., Sykes, D. E. & Weiser, M. M. 1991. The 
effect of vitamin D on rat intestinal plasma membrane Ca-pump mRNA. 
Biochem Biophys. Res. Commun. 179:749-755. 
42 
REGULATION OF RAT INTESTINAL 
CaATPase AND CaBP mRNA BY 1,25-
DIHYDROXYVITAMIN D3 AND 1,25,28-
TRIHYDROXYVITAMIN D2 
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Abstract 
1,25-dihydroxyvitamin D3 is a primary regulator of intestinal active 
calcium transport. The purpose of this study was to determine the changes 
in intestinal vitamin D-dependent plasma membrane calcium ATPase 1 
[PMCAl] and calcium binding protein-9K [CaBP-9K] mRNA induced by a 
single injection of 1,25-dihydroxyvitamin D3 or an analog of 1,25-
dihydroxyvitamin D3 that is considered non-hypercalcemic, 1,25,28-
trihydroxyvitamin D2, in vitamin D-deficient rats. The results of Northern 
blotting of duodenal tissues indicated that a single injection of 20 ng of 
1,25-dihydroxyvitamin D3 per rat doubled intestinal PMCAl at 4, 8, and 
12 hours after injection, and CaBP-9K mRNA was increased at 8, 12, 
and 24 hours after injection. No increase in PMCAl and CaBP-9K mRNA 
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was observed in duodenum of rats receiving an injection of 1 ug of 
1,25,28-trihydroxyvitamin D2, which also had no effect on plasma calcium 
concentration. However, the mRNA of PMCAl and CaBP-9K could be 
increased by a larger dose of 1,25,28-trihydroxyvitamin D2 [20 jig], which 
was accompanied by an increase in plasma calcium. These data suggest that 
upregulation of PMCAl and CaBP-9K mRNA may be critical to active 
calcium transport in the intestine. 
Introduction 
Active calcium transport in the intestine involves three steps: 1. 
calcium diffusion into brush border membrane of the enterocyte down its 
concentration gradient; 2. translocation of free or bound calcium to the 
basolateral membrane; and 3. active extrusion of calcium across basolateral 
membrane against a concentration gradient (3, 31). Inside cells, calcium 
binding protein serves as an intracellular calcium "carrier" (31). At 
the basolateral membrane, calcium ATPase [CaATPase] pumps calcium into 
the extracellular fluid against a concentration gradient. 
The active metabolite of vitamin D, 1,25-dihydroxyvitamin D3 
[1,25-D3] is a primary regulator of calcium and phosphorus transport in 
the intestine. As with other steroid hormones, 1,25-D3 binds to specific 
intracellular receptors, i.e., vitamin D receptors [VDR], to initiate 
transcription and translation of various gene products (14, 15, 23, 24). 
Two gene products thought to be involved in calcium transport are 
CaATPase and CaBP (11, 17-22, 24, 35). However, some observations are 
inconsistent with the theory of direct involvement of vitamin D in calcium 
translocation. For example, a recent report indicated that, in vitamin D-
repleted rats, duodenal calcium transport was enhanced by a single 
injection of calcitriol, whereas CaBP-9K stayed essentially unchanged (5). 
This conflicts with reports of studies that increased calcium transport 
coincided with increased CaBP (6, 8, 29, 30). It has been demonstrated 
that 1,25-D3 upregulates PMCAl mRNA in rat and chick intestine (1,4, 
35), but recent reports reveal that 1,25-D3 does not enhance the synthesis 
of intestinal PMCA (27, 28), and did not affect ATP-dependent basolateral 
membrane calcium efflux (10). Therefore, it is important to re-evaluate 
the transcriptional regulation of PMCAl and CaBP-9K by 1,25-D3. 
Although analogs and metabolites of vitamin D have been tested for 
their calcitropic activity, few reports have documented the effects of these 
compounds on gene expression (34). It was reported that doses as high as 
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800 ng of 1,25,28-trihydroxyvitamin D2 [1,25,28-D2] did not affect rat 
intestinal calcium transport, but doses as little as 250 ng of 1,25,28-D2 
upregulated intestinal CaBP mRNA (34). No changes in plasma calcium 
have been found in vitamin D-deficient rats injected with 7 ug of 1,25,28-
D2 per day for three months (Horst and Reinhardt, unpublished). These 
data suggest that upregulation of CaBP was not the only limiting factor in 
intestinal calcium transport in these experiments. In this study, we 
determined whether upregulation of both CaATPase and CaBP-9K were 
limiting factors in intestinal calcium transport by comparing the effects of 
1,25-D3 and 1,25,28-D2 [at doses that did and did not cause an increase in 
plasma calcium] on mRNA expression of calcium ATPase and CaBP-9K in 
intestinal tissue of rats. 
Materials and Methods 
Animals: Three week-old male Holtzman Sprague-Dawley 
weaning rats were fed a synthetic calcium deficient [-Ca], vitamin D 
deficient [-D] diet [ 0.002% calcium, 0.41 % phosphate] (Tekland, 
Madison, WI) for three weeks to induce vitamin D deficiency and 
hypocalcemia. Treatment groups consisted of 4-5 rats. 
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In trial 1, rats were injected i. p. with 20 ng of 1,25-D3 or 20 ug of 
1,25,28-D2 at 4, 8,12 and 24 h prior to sacrifice. 
In trial 2, rats were injected i. p. with 20 ng of 1,25-D3 or 1 ug of 
1,25,28-D2 at 4, 8, 12, 16, 24 and 36 hours prior to sacrifice. Control rats 
received no injection. Rats were killed by inhalation of CO2-O2 [50:50] 
followed by exsanguination. Blood samples were collected into heparinized 
tubes. The proximal 15 cm of duodenum mucosa was collected from each 
rat and frozen for later mRNA analysis. 
Northem blotting: Plasma CaATPase and CaBP-9K mRNA 
levels were determined by Northem blotting. Total RNA was isolated by 
TRIzol and chloroform, precipitated and washed by isopropanol and 
ethanol (GIBCO, BRL, Gaithersburg, MD). PolyA-containing RNA was 
selected via oligo dT cellulose affinity chromatography (2). RNA was 
fractionated on 1.2% formaldehyde agarose gel and transferred to nylon 
membranes (MSI Micro Separations Inc., Westboro, MA). The RNA on 
the membranes was cross-linked by Stratalinker 1800 (Stratagene, La Jolla, 
CA). A 3.4 kb cDNA from rat brain plasma membrane calcium ATPase 
[PMCAl], kindly supplied by Dr Gary Shull, University of Cincinnati, OH, 
was used to hybridize the membranes for analysis of CaATPase mRNA. 
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The cDNA for CaBP-9K mRNA assay was the gift of Dr. M. Elizabeth 
Brims, University of Virginia Medical School, Charlottesville, VA. 
Membranes were prehybridized at 42® C for 4-6 hours in a 
prehybridization buffer containing 50% formamide, 5X Denhardt's 
reagent, 0.1% sodium dodecyl sulfate [SDS] and 100 ug/ml denatured fish 
sperm DNA. Fresh prehybridization buffer and 250 ug tRNA was used for 
the overnight membrane hybridization with 5 x 106 cpm 32p.iabeled 
cDNA probe/ml prehybridization buffer. The membranes were washed 
twice in 2X SSPE/0.1% SDS buffer [SSPE is NaCl, NaP2P04, EDTA 
mixture], twice in 0.1% SSPE/0.1% SDS, each for ten minutes. 
Quantitative analysis of mRNA was done by Scanalytics AMBIS imaging 
systems (Division of CSPI, San Diego, CA). A 2.1 kb chick P-actin cDNA 
probe was obtamed by digestion of pBR322 with Hind HI (7) and used as a 
control for estimation of mRNA integrity and RNA sample loading 
difference among various preparations. 
Plasma calcium concentrations were determined by atomic 
absorption spectrophotometry (Perkin-Elmer Corp., Norwalk, CT). 
Analysis of variance was used to determine if differences existed 
among CaATPase, CaBP-9K mRNA levels and plasma calcium 
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concentrations at each time point. When ANOVA suggested differences 
existed, Dunnett multiple comparisons were used to test the significance 
between mRNA levels at time 0 with all other time points. 
Results 
Intestinal PMCAl mRNA concentration increased 1.89-, 1.94- and 
1.77-fold at 4, 8, 12 hours after injection of 20 ng 1,25-D3 [p< 0.01 at 4 
and 8 hours and p<0.05 at 12 hours respectively] (Figure 1, 3 and Table 1) 
when compared with time 0. PMCAl mRNA concentration increased 2.1-
fold at 8 hours after treatment with 20 ug of 1,25,28-D2 [p<0.01] (Figure 
2, 3 and Table 1). A significant increase of CaBP mRNA was also found at 
8, 12 and 24 hours after injection of 20 ng of 1,25-D3 (Figure 4, 6 and 
Table 2 ) and at 4, 8,12 and 24 hours after injection of 20 ug of 1,25,28-
D2 (Figure 5, 6 and Table 2). However, injection of 1 ug of 1,25,28-D2 
failed to increase either PMCAl or CaBP-9K mRNA levels (Figure 7 and 
8). 
Interestingly, significantly higher plasma calcium concentrations 
were observed at 4, 8 and 12 hours after injection of 20 ug of 1,25,28-D2 
(Figure 9, Table 3). No significant increase of plasma calcium occurred 
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after injection of 20 ng of 1,25-D3 at any time point when compared to 
time 0 (Figure 10, Table 3). 
Discussion 
Active calcium transport across the intestine involves calcium entry 
across the brush border of enterocytes, transport of the calcium across the 
cell mediated by CaBP and extrusion across the basolateral membranes of 
the intestinal epithelial cells by basolateral membrane CaATPase (33). In 
the intestine, 1,25-D3 enhances calcium transport, in part, by stimulating 
vitamin D-dependent CaBPs mRNA expression and protein synthesis (13, 
16,18, 24-26), and enhancing epithelial cell CaATPase mRNA expression, 
protein synthesis and activity (11, 17, 19-22, 32, 35). 
Our data indicate that administration of 1,25-D3 to vitamin D 
deficient rats upregulate intestinal PMCAl and CaBP-9K mRNA. The 
upregulation of PMCAl mRNA by 1,25-D3 peaked at 4 and 8 hours after 
injection and remained high at 12 hours. Also, 1,25-D3 induced more 
prolonged induction of PMCAl mRNA than did 1,25,28-D2. Compared to 
that of PMCAl mRNA expression, the response of CaBP-9K mRNA to 
1,25-D3 peaked at 8 and 12 hours after injection, which is in agreement 
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with earlier reports (1, 4, 6, 8, 35). 
A report from Wang et al. (34) demonstrated that 12.5 ng of 
1,25,28-D2 did not have any effects on intestinal calcium absorption, 
intestinal CaBP-9K mRNA or CaBP-9K protein. Treatment with 250, 500 
or 800 ng 1,25,28-D2 resulted in significant induction of CaBP mRNA but 
still failed to increase intestinal calcium absorption. To the best of our 
knowledge, no reports on the induction of CaATPase mRNA by 1,25,28-
D2 have been documented. Our results from a single injection of 1,25,28-
D2 into vitamin D-deficient rats indicated that no induction of intestinal 
CaATPase and CaBP-9K mRNA occurred when 1 ug of 1,25,28-D2 was 
used, but induction of both CaATPase mRNA and CaBP-9K was obvious 
after injection of 20 ug of 1,25,28-D2 and this was accompanied by higher 
plasma calcium levels. The rapid transcriptional responses are probably 
due to the binding of hormone-receptor complexes to, and the cellular 
responses from the responsive genes of vitamin D. The low affinity [0.8% 
of that of 1,25-D3] of 1,25,28-02 to vitamin D receptors probably 
contributes, at least in part, to the experimental results in which large doses 
of the analog induced multiple cellular responses to elevate blood calcium 
concentrations. The rapid transcriptional response of both CaATPase and 
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CaBP-9K indicate that 1,25-D3 is a primary regulator of calcium transport 
system in the intestine (9). 
Acknowledgment 
The authors wish to thank Dr. Richard L. Engen, Dr. Franklin A. 
Ahrens, Dr. Donald C. Beitz for all their support of the project. The 
authors also thank Derrel A. Hoy, Judy M. Pochop, Cynthia A. Hauber, K. 
C. Hummel, Mary Kassinos and Gary Fry for their technical support. 
References 
1. Armbrecht, H. J., Boltz, M. A. & Wongsurawat, N. 1994. 
Expression of plasma membrane calcium pump mRNA in rat intestine: 
effect of age and 1,25-dihydroxyvitamin D. Biochim. Biophys. Acta 
1195:110-114. 
2. Aviv, H. & Leder, P. 1972. Purification of biologically active 
globin messenger RNA by chromatography on oligothymidylic acid-
cellulose. Proc. Natl. Acad. Sci. USA 69:1408-1412. 
3. Bronner, F. 1992. Current concepts of calcium absorption: an 
overview. J. Nutr. 122:641-643. 
4. Cai, Q., Chandler, J. S., Wasserman, R. H., Kumar, R. & 
Penniston, J. T. 1993. Vitamin D and adaptation to dietary calcium and 
phosphate deficiencies increase intestinal plasma membrane calcium pump 
gene expression. Proc. Natl. Acad. Sci. USA 90:1345-1349. 
52 
5. Chabanis, S., Hanrotel, C., Duchambon, P., Banide, H., 
Kubrusly, M., Aymard, P., Lacour, B. & Drueke, T. 1994. 
Duodenal calcium binding protein and active transport in rats: are they 
functionally related? Nephrol. Dial. Transplant. 9:1402-1407. 
6. Christakos, S,, Gabrielides, C. & Rhoten, W. B. 1989. Vitamin 
D-dependent calcium binding proteins: chemistry, distribution, functional 
considerations, and molecular biology. Endocine Rev. 10:3-16. 
7. Cleveland, D. W., Lopata, M. A., MacDonald, R. J., Cowan, 
N. J., Rutter, W. J. & Kirschner, M. W. 1980. Number and 
evolutionary conservation of a a and P tubulin and cytoplasmic p and y 
actin genes using specific cloned cDNA probes. Cell. 20:95-105. 
8. Darwish, H. M. & DeLuca, H. F. 1992. Identification of a 1,25-
dihydroxyvitamin D3 response element in the 5'-fianking region of rat 
calbindin D-9K gene. Proc. Natl. Acad. Sci. U. S. A. 89:603-607. 
9. DeLuca, H. F. 1988. The vitamin story: a collaborative effort of basic 
science and clinical medicine. FASEB J. 2:224-236. 
10. Favus, M. J., Tembe, V., Ambrosic, K. A. & Nellans, H. N. 
Effects of 1,25-dihydroxyvitamin D3 on enterocyte basolateral membrane 
calcium transport in rats. 1989. Am. J. Physiol. G613-G617. 
11. Ghijsen, W. E. & Van Os C. H. 1982. 1,25-dihydroxyvitamin D3 
regulates ATP-dependent calcium transport in basolateral plasma 
membranes of rat enterocytes. Biochim. Biophys. Acta. 689:170-172. 
12. Ghijsen, W. E., Dejong, M. D. & van Os, C. H. 1982. ATP-
dependent calcium transport and its correlation with Ca2+-ATPase activity 
in basolateral plasma membranes of rat duodenum. Biochim. Biophys. 
Acta. 689:327-336. 
13. Gross, M. & Kumar, R. 1990. Physiology and biochemistry of 
vitamin D-dependent calcium binding proteins. Am. J. Physiol. 259:F195-
F209. 
53 
14. Ham, J. and Parker, M. G. 1989. Regulation of gene expression by 
nuclear hormone receptors. Curr. Opin. CeU Biol. 1:503-511. 
15. Haussler, M. R. 1986. Vitamin D receptors: nature and function. 
Annu. Rev. Nutr. 6:527-562. 
16. Heimann, C. W. & Hunziker, H. 1990. Intracellular calcium 
binding molecules. In: Bronner, F. (ed) Intracellular calcium regulation. 
Alan. R. Liss Inc., New York, p 211. 
17. Kumar, R. 1986. The metabolism and mechanism of action of 1,25-
dihydroxyvitamin D3. Kidney Int. 30:793-803. 
18. Kumar, R. 1991. Vitamin and calcium transport. Kid. Int. 40:1177-
1189. 
19. Lane, S. M. & Lawson, D. E. M. 1978. Differentiation of the 
changes in alkaline phosphatase from calcium ion-activated adenosine 
triphosphatase activities associated with increased calcium absorption in 
chick intestine. Biochem. J. 174:1067-1070. 
20. Martin, D. L., Melancon, M. J. & DeLuca, H. F. 1969. 
Vitamin D stimulated, calcium-dependent adenosine triphosphatase from 
brush borders of rat small intestine. Biochem. Biophys. Res, Conmiun. 
35:819-823. 
21. Marx, S. J., Liberman, U. A. & Eil, C. 1983. Calciferols: 
actions and deficiencies of action. Vitam. Horm. 40:235-308. 
22. Melancon, M. J. & DeLuca, H. F. 1970. vitamin D stimulation of 
calcium-dependent adenosine triphosphatase in chick intestinal bmsh 
borders. Biochemistry. 9:1658-1664. 
23. Minghetti, P. P. & Norman, A. W. 1988. 1,25-dihydroxyvitamin 
D3 receptors: gene regulation and genetic circuitry. FASEB J. 2:3043-
3053. 
54 
24. Norman, A. W., Roth, J. & Orel, L. 1982. The vitamin D 
endocrine system: steroid metabolism, hormone receptors and biological 
response (calcium binding proteins). Endoc. Rev. 3:331-366. 
25. Pavlovitch, J. H., Didierjean, L., Rizk, M., Balsan, S. & 
Saurat, J. H. 1983. Skin calcium-binding protein: distribution in other 
tissues. Am. J. Physiol. 244:C50-C57. 
26. Schelling, C. P., Didierjean, L., Rizk, M., Panlovitch, J. H., 
Takagi, T. & Heimann, C. W. 1987. Calcium-binding proteins in rat 
skin. FEES Lett. 214:21-27. 
27. Takito, J., Shinki, T., Tanaka, H. & Suda, T. 1992. Mechanism 
of regulation of calcium pumping activity in chick intestine. Am. J. 
Physiol. 262:G797-G805. 
28. Timmermans, J. A., Kaune, R., Bindels, R. J. & van Os, C. 
H. 1991. Quantification of Ca(2+)-ATPases in porcine duodenum. Effect of 
I,25-dihydroxyvitamin D3 deficiency. Biochim. Biophys. Acta 1065:177-
184. 
29. Wasserman, R. H. 1981. Intestinal absorption of calcium and 
phophorus. Fed. Proc, 40:68-72. 
30. Wasserman, R. H., Fullmer, C. S. & Shimura, F. 1984. 
Calcium absorption and the molecular effects of vitamin D3, in Vitamin D: 
basic and clinical aspects, edited by Kumar, R., Boston, Martinus Nijhoff. p 
233-302. 
31. Wasserman, R. H., Chandlwer, J. S., Meyer, S. A., Smith, 
C. A., Brindak, M. E., Fullmer, C. S., Penniston, J. T. & 
Kumar, R. 1992. Intestinal calcium transport and calcium extrusion 
processes at basolateral membrane. J. Nutr. 122:662-671. 
32. Wasserman, R. H., Smith, C. AS., Brindak, M. E., 
Talamoni, N. D., Fullmer, C. S., Penniston, J. T. & Kumar, R. 
1992. Vitamin and mineral deficiencies increase the plasma membrane 
calcium pump of chick intestine. Gastroenterology. 102:886-894. 
55 
33. Wasserman, R. H. & Fullmer, C. S. 1995. Vitamin D and 
intestinal calcium transport: facts, speculations and hypotheses. J. Nutr. 
125:1971S-1979S. 
34. Wang, Y. Z.j Li, H., Bruns, M. E., Uskokovic, M., Truitt, 
G. A., Horst, R., Reinhardt, T., and Christakos, S. 1993. Effect of 
1,25,28-trihydroxyvitamin D2 and 1,24,25-trihydroxyvitamin D3 on 
intestinal calbindin-D9K mRNA and protein: Is there a correlation with 
intestinal calcium transport? J. Bone Miner. Res. 8:1483-1490. 
35. Zelinski, J. M., Sykes, D. E. & Weiser, M. M. 1991. The 
effect of vitamin D on rat intestinal plasma membrane Ca-pump mRNA. 
179:749-755. 
loieitinal CaATPase mRNA (relative value] 
57 
0 4 8 12 24 
Hours after 20 ug of 1,25,28-02 injecdon 
Figure 2. Tntesrinal CaAlPase mRNA expression after 1,25,28-02 injection 
58 
Litesnnai 
CaATPase mRNA 
1 2 3 4 5 6 7 8 9  
Hgure 3. Northern blot of intestmal CaATPase mRNA 
1. Comrol 
2.4 hours after 20 ng of 1,2S-D3 injectioii 
3. 4 hours after 20 ug of 1 ,^28-D2 injection 
4. 8 hours after 20 ng of 1,2S-D3 injection 
5. 8 hours after 20 ug of 1,25,28-D2 injection 
6.12 hours after 20 ng of l^-Ds injection 
7.12 hours after 20 ug of IJ2S^'D2 injection 
8.24 hours after 20 ng of 1,2S-D3 injection 
9. 24 hours after 20 ug of 1,25,28-D2 injection 
S" 
•d 
> 
ct 
S M S' p 
% 
bi 
6 
E a 
B. 
§ 
& 
S» 
#—« 
u 
6 ta 
s: a 
3. 
00 
N> 
Intestiiul CaBP mRNA (relative value] 
' to UJ 
00 
K3 
Intestinal CaBP mRNA (velative value] 
to 
61 
Intesdnal 
CaBP mRNA 
1 2 3 4 5 6 7 8 9  
Figure 6. Nonfaem blot of intrsnnai CaBP mRNA 
I. Control 
2.4 hours after 20 ng of 1,25-D3 injection 
3.4 hours after 20 ug of 1 ,^28-02 injection 
4. 8 hours after 20 ng of 1,25-D3 injection 
5.8 hours after 20 ug of 1,25,28-02 injection 
6.12 hours after 20 ng of 1,25-03 injection 
7.12 hours after 20 ug of 1,25,28-02 injection 
8.24 hours after 20 ng of 1,25-03 injection 
9.24 hours after 20 ug of 1,25,28-02 injection 
62 
Intesnnai 
CaATPase mRNA 4MMIM 
0-actin 
I 2 3 4 5 6 7 a 9 10 11 12 13 
Hguie 7. Nortfaem blot of intesnnai CaATPase mRNA 
I. Control 
2.4 hours after 20 ng of l^-Ds injection 
3.4 hours after 1 ug of 1,25«28-D2 injection 
4.8 hours after 20 ng of 1,25-D3 injection 
5.8 hours after 1 ug of 1 ,^28-D2 injection 
6.12 hours after 20 ng of 1,25-03 injection 
7.12 hours after 1 ug of 1,25,28-02 injection 
8.16 hours after 20 ng of 1,25-03 injection 
9.16 hours after 1 ug of 1,25,28-02 injection 
10.24 hours after 20 ng of 1,25-03 injection 
II.24 hours after 1 ug of 1,25,28-02 injection 
12.36 hours after 20 ng of 1,25-03 injection 
13.36 hours after 1 ug of 1,25,28-02 injection 
63 
CaBP mRNA 
p-acdn 
Intestinal 
1 2 3 4 S 6 7 8 9 10 11 12 13 
Figure 8. Nortiiem blot of intestinai CaBP mRNA 
I. Control 
2.4 hours after 20 ng of 1,25-03 injection 
3. 4 hours after 1 ug of 1,25,28-D2 injection 
4. 8 hours after 20 ng of 1,25-03 injection 
5. 8 hours after 1 ug of 1,25,28-02 injection 
6.12 hours after 20 ng of 1,25-03 injection 
7.12 hours after 1 ug of 1,25,28-02 injection 
8.16 hours after 20 ng of 1,25-03 injection 
9.16 hours after 1 ug of 1,25,28-02 injection 
10. 24 hours after 20 ng of 1,25-03 injection 
II.24 hours after 1 ug of 1,25,28-02 injection 
12.36 hours after 20 ng of 1,25-03 injection 
13.36 hours after 1 ug of 1,25,28-02 injection 
64 
51 
0 4 8 12 24 
Hours after 20 ng of l^-Ds injection 
Figure 9. Plasma calcium concentration after 1»25-D3 injection 
65 
0 4 8 12 24 
Hours after 20 ug of i;25^8-D2 injection 
Figure 10. Plasma calcium concentration after 1,25^8-02 injection 
66 
Table 1. Intestinal CaATPase mRNA [relative value] 
Hours after injection 1, 25-D3 treatment 1,25,28-D2 treatment 
Mean SD Mean SD 
0 1.00 0 1.00 0 
4 1.89** 0.48 1.73* 0.39 
8 1.94** 0.17 2.11** 0.59 
12 1.77* 0.16 1.36 0.16 
24 1.12 0.54 1.20 0.22 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
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Table 2. Intestinal CaBP mRNA [relative value] 
Hours after injection 1, 25-D3 treatment 1,25,28-D2 treatment 
Mean SD Mean SD 
0 1.00 0 1.00 0 
4 1.07 0.08 1.61** 0.09 
8 2.36** 0.22 1.81** 0.12 
12 1.74** 0.10 2.37** 0.18 
24 1.72** 0.16 2.07** 0.13 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
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Table 3. Plasma calcium concentration [mg/dl] 
Hours after injection 1, 25-D3 treatment 1,25,28-D2 treatment 
Mean SD Mean SD 
0 3.48 0.10 3.48 0.10 
4 3.69 0.27 4.34** 0.23 
08 3.95 0.35 4.87** 0.30 
12 4.18 0.53 4.51** 0.62 
24 4.05 0.71 3.86 0.12 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
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EFFECT OF DIETARY CALCIUM AND VITAMIN 
D RESTRICTION ON RAT INTESTINAL 
CALCIUM ATPase AND CALCIUM BINDING 
PROTEIN mRNA EXPRESSION 
A paper to be submitted to the J. of Bone and Miner. Res. 
Yingting Zhu, Jesse P. Goff, Timothy A. Reinhardt and Ronald L. Horst 
Abstract 
Vitamin D deficiency prevents the active transport of calcium across 
the intestine. Modulation of calcium pump and calcium binding protein 
gene expression by dietary vitamin D and calcium restriction is still not 
well understood. In this study, the effects of dietary calcium and/or 
vitamin D-deficiency on intestinal plasma membrane calcium ATPase 
[PMCAl] and calcium binding protein [CaBP-9K] mRNA expression in rats 
was examined. The results indicate both intestinal PMCAl and CaBP-9K 
mRNA are downregulated in rats fed diets containing no vitamin D. 
However, dietary calcium restriction alone did not increase CaATPase or 
CaBP-9K mRNA. This study demonstrates that dietary calcium itself is 
probably not a major regulator in mRNA expression of calcium 
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transporting factors such as PMCAl and CaBP-9K when physiological 
doses of vitamin D are supplied in diet. 
Introduction 
Dietary calcium absorption in the intestine can be transcellular or 
paracellular (6). The transcellular movement is dominant in the small 
intestine (27). In transcellular movement, the entry of calcium into cells 
can occur by simple diffusion across the plasma membrane and is 
dependent on the electrochemical gradient of calcium through calcium 
channels or exchangers (1, 38). After entry into the epithelial cell, calcium 
binding protein transports calcium to the basolateral membrane where 
CaATPase pumps calcium out of the cell against its concentration gradient 
into the extracellular fluids (39). 
It is well known that 1,25-dihydroxyvitamin D3 [I25-D3] is a 
primary regulator of intestinal calcium absorption (24, 27, 36). The 
vitamin stimulates calcium transport by classic hormone-receptor-mediated 
processes (10, 24). 1,25-D3 markedly enhances CaATPase mRNA 
concentration and activity and elevates CaBPs and their mRNA (14, 15, 17-
22, 26, 30, 41). 
Whether calcium restriction induces upregulation of CaATPase and 
CaBP is controversial. Favus et al. (12) reported that the intestinal calcium 
transport in rats adapted to a calcium-deHcient diet was decreased (12). 
Brehier (5) indicated that calcium induced a 6- to 10-fold increase of 
CaBP-9K mRNA, which could be blocked by actinomycin D in duodenal 
organ culture. deBoland and Norman (9) demonstrated that stimulation of 
duodenal calcium transport in chicks by 1,25-D3 was dependent on the 
presence of calcium in the media, since transport was abolished by prior 
addition of EGTA and was restored upon addition of calcium. Meyer et 
al. (23) reported that reduced dietary calcium increased intestinal CaBP 
mRNA, but at the same time diminished vitamin D receptor [VDR] mRNA 
despite increased circulating 1,25-D3. Theofan et al. (37) found that there 
was no difference in steady state intestinal CaBP mRNA levels between rats 
fed low or normal calcium diet. Hall and Norman (16) indicated that, in 
vitamin D deficient rats, dietary calcium manipulation did not affect 
intestinal CaBP or its mRNA in chicks; however, a single injection of 1,25-
D3 induced both duodenal CaBP and CaBP mRNA. Some earlier reports 
suggested that the adaptation to a calcium-deficient diet was associated with 
increased CaBPs and CaBP mRNA (3, 4, 13, 25, 29, 31, 34). Moreover, 
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Wassennan et al. (39, 40) found that mineral deficiencies increased the 
plasma membrane CaATPase of chick intestine. Cai et al. (7) claimed that 
adaptation to dietary calcium deficiencies increased intestinal CaATPase 
gene expression. These discrepancies suggest that it is important to 
evaluate whether the adaptation to calcium deficiencies can induce gene 
expression of intestinal calcium transporting factors such as CaATPase and 
CaBP. 
Materials and Methods 
Animals: In trial 1, three-week old Holtzman Sprague-Dawley 
weaning rats were placed on four different synthetic diets, i.e., +Ca, +D 
diet [1% calcium, 5 lU vitamin D/g] (Tekland, Madison, WI); 2. -Ca, -D 
diet [0.002 % calcium, 0 lU vitamin D/g]; 3. -D diet [0.5% calcium, 0 lU 
vitamin D/g]; 4. -Ca diet [0.002% calcium, 5 lU vitamin D/g] for three 
weeks to induce vitamin D- and/or calcium-deficient state. In trial 2, the 
rats were fed a normal diet or a -Ca diet for 1 week, 2 weeks or 3 weeks. 
Rats were killed by inhalation of CO2-O2 [50:50] followed by 
exsanguination. Blood samples were collected into heparinized tubes. The 
proximal 15 cm of duodenal mucosa was collected from each rat and 
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frozen for later mRNA analysis. 
Northern blotting: Intestinal CaATPase, CaBP and VDR mRNA 
levels were determined by Northem blotting. Total RNA was isolated by 
TRIzol (GIBCO, BRL, Gaithersburg, MD) and chloroform, precipitated 
and washed by isopropanol and ethanol. PolyA-containing RNA was 
selected by oligo dT cellulose affinity chromatography (2). RNA was 
fractionated on 1.2% formaldehyde agarose gel and transferred to nylon 
membranes (MSI Micro Separations Inc., Westboro, MA). The RNA was 
cross-linked by Stratalinker 1800 (Stratagene, La Jolla, CA). A 3.4 kb 
cDNA from rat brain plasma membrane CaATPase [PMCAl], kindly 
supplied by Dr. Gary Shull, University of Cincinnati, OH, was used to 
hybridize the membranes for analysis of CaATPase mRNA. The cDNA 
for CaBP-9K mRNA assay was a gift of Dr. M. Elizabeth Bruns, 
University of Virginia Medical School, Charlottesville, VA. 
Membranes were prehybridized at 42® C for 4-6 hours in a 
prehybridization buffer containing 50% formamide, 5X Denhardt's 
reagent, 0.1% sodium dodecyl sulfate [SDS] and 100 ug/ml denatured fish 
sperm DNA. Fresh prehybridization buffer and 250 ug tRNA was used for 
the ovemight membrane hybridization with 5 x 10^ cpm 32p-iabeled 
74 
cDNA probe/ml prehybridization buffer. The membranes were washed 
twice in 2X SSPE/0.1% SDS buffer [SSPE is NaCl, NaH2P04, EDTA 
mixture], twice in O.IX SSPE/0.1% SDS, each for 10 minutes. 
Quantitative analysis of mRNA was done by Electronic Autoradiography 
(PACKARD, Meriden, CT). A 2.1 kb chick p-actin cDNA probe was 
obtained by digestion of pBR322 with Hind HI (8) and used as a control for 
estimation of mRNA integrity and RNA sample loading difference among 
various preparations. 
Plasma 1,25-D3 determination: The method of Reinhardt et al (32) 
was modified to determine 1,25-D3 concentration in plasma. The plasma 
1,25-D3 was chromatographed on C18/0H low hydrocarbon columns 
(Varian, Harbor City, CA), and the concentration was determined by 
radio-receptor assay. Recovery of [3H]i^25-D3 through the purification 
steps for each sample allowed correction for extraction efficiency. 
Plasma calcium concentrations were determined by atomic 
absorption spectrophotometry (Perkin-Elmer Corp., Norwalk, CT). 
Analysis of variance was used to determine if differences among 
CaATPase, CaBP, VDR mRNA and plasma constituents as a result of 
different dietary treatment. When ANOVA suggested differences existed, 
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Dunnett multiple comparisons test was used to test the significance between 
each dietary treatment. 
Results 
In trial 1, intestinal CaATPase and CaBP mRNA decreased 
significantly in the duodenum of rats fed -D diets, regardless of dietary 
calcium (Figure 1, 2, 3, 4, Table 1 and 2). Intestinal CaATPase and CaBP-
9K mRNA levels were unaffected by dietary calcium treatment in vitamin 
D-replete rats (Figure 1, 2, 3, 4, Table 1 and 2). In trial 2, intestinal 
calcium ATPase mRNA was unaffected in rats after 1, 2 and 3 weeks of 
dietary calcium restriction (Figure 5). CaBP mRNA did not increase after 
1, 2, 3 weeks of calcium restriction (Figure 6). No increase of either 
CaATPase or CaBP mRNA was observed, despite the significantly higher 
level of plasma 1,25-D3 in rats fed -Ca diet. Plasma 1,25-D3 
concentrations in all rats fed -D diet with 0% calcium or 1% calcium 
were low (Figure 7 and Table 3). Plasma calcium levels in vitamin D-
deficient rats were lower than those in vitamin D-replete rats, regardless of 
dietary calcium. Plasma calcium levels in rats fed -Ca diet were 
significantly lower than those in rats fed 1% calcium diet, but higher than 
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those in rats fed vitamin D-deficient diets (Figure 8 and Table 4). 
Discussion 
Our results clearly demonstrate that vitamin D deficiency with or 
without calcium deficiency induced similar downregulation of both 
intestinal CaATPase and CaBP mRNA, indicatmg that vitamin D, not 
calcium, is a major regulator of active calcium transporting factors (11, 
24, 27, 34, 36). Dietary calcium itself did not seem to play a major role in 
gene transcription of CaATPase and CaBP, but the published papers on this 
topic are contradictory (3-5, 7, 9, 12, 13, 16, 23, 25, 29, 31, 35, 37, 40). 
Recently, Meyer et al (7) and Cai et al (23) reported that restriction of 
dietary calcium could induce upregulation of CaBP and CaATPase mRNA. 
However, our experiments failed to demonstrate upregulation of CaATPase 
or CaBP mRNA, implying that restriction of calcium may not induce 
adaptive upregulation of gene transcription of calcium transporting factors. 
This is in agreement with recent reports in which negative results of 
calcium deficiencies on the gene expression of CaATPase and CaBP have 
been reported (5, 12, 16, 37). The significantly higher plasma 1,25-D3 in 
rats fed -Ca diet failed to upregulate vitamin D dependent CaATPase and 
77 
CaBP-9K mRNA. Whether the hypocalcemia counteracts the action of 
increased 1,25-D3 is unknown (9, 33). Higher levels of plasma calcium in 
rats fed -Ca diet, compared to that in rats fed -D diet, also suggests vitamin 
D, not calcium, is a primary regulator of calcium homeostasis (24, 27, 36). 
The mechanism by which intestinal calcium transport is increased under 
conditions of low dietary calcium concentration remains questionable and 
needs further studies. 
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Appendix with mean data tables 
1.21 
12 3 4 
+Ca+D -Ca-D +Ca-D -Ca+D 
Figure 1. Intestinal CaATPase mRNA expression in rats fed different diets 
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Hgure 2. Northem blot of Intestinal CaATPase mRNA 
1. -i-Ca-t'O diet treatment 
2. -Ca-D diet treatment 
3. -iCa-D diet treatmem 
4. -Ca-f-0 diet treatment 
Intestinal CaBP mRNA [relative value] 
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Figure 4. Northern blot of Tntestinal CaBP mRNA 
1. +Ca+D diet treatment 
2. -Ca-O diet treatment 
3. -^Ca-D diet treatment 
4. -Ca-f-D diet treatment 
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Intestinal CaATPase mRNA 
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Figure 5. Northern blot of Ihtestmal CaATPase mRNA 
1. diet treatment, 1 week 
2. -Ca-kO diet treatment, 1 week 
3. •fCa'4'0 diet treatment, 2 weeks 
4. -Ca+D diet treatment, 2 weeks 
5. -iCa-fO diet tteattient, 3 weeks 
6. -Ca+D diet treatment, 3 weeks 
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Figure 6. Northern blot of Intestinal CaBP mRNA 
1. +Ca+D diet treatment, 1 week 
2. -Ca-hD diet treatment, 1 week 
3. +Ca-fO diet treatment, 2 weeks 
4. -Ca+D diet treatment, 2 weeks 
5. +Ca-t-D diet treatment, 3 weeks 
6. -Ca-HD diet treatment, 3 weeks 
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Figure 7. Plasma 1,25-D3 concentration in rats fed di£ferent diets 
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Figure 8. Plasma caH"*" conceatradon in rats fed different diets 
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Table 1. Intestmal CaATPase mRNA [relative value] 
Dietary treatment Mean SD 
+Ca+D 1.00 0 
-Ca-D 0.50** 0.17 
+Ca-D 0.59** 0.19 
-Ca+D 0.84 0.13 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 samples. 
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Table 2. Intestiiial CaBP mRNA [relative value] 
Dietary treatment Mean SD 
+Ca+D 1.00 0 
-Ca-D 0.34** 0.26 
+Ca-D 0.20** 0.07 
-Ca+D 1.00 0.44 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 samples. 
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Table 3. Plasma 1,25-03 concentration [pg/ml] 
Dietary treatment Mean SO 
+Ca+D 80.8 11.5 
-Ca-D 15.6** 9.80 
+Ca-D 7.80** 3.90 
-Ca+D 622.4** 40.9 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
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Table 4. Plasma calcium concentration [mg/dl] 
Dietary treatment Mean SD 
+Ca+D 8.30 0.30 
-Ca-D 3.80** 0.20 
+Ca-D 4.40** 0.30 
-Ca+D 6.10** 0.30 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
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PREGNANCY AND LACTATION INCREASE 
VITAMIN D-DEPENDENT INTESTINAL 
MEMBRANE CALCIUM ATPase AND CALCIUM 
BINDING PROTEIN mRNA EXPRESSION 
A paper to be submitted to the J. of Bone and Miner. Res. 
Yingting Zhu, Jesse P. Goff, Timothy A. Reinhardt and Ronald L. Horst 
Abstract 
The calcium demands of pregnancy and lactation are known to 
upregulate intestinal calcium absorption. Intestinal epithelial cells contain 
calcium ATPases and calcium binding proteins, which are believed to play 
important roles in intestinal calcium transport. However, the possible role 
for these two proteins in the upregulation of intestinal calcium absorption 
observed in pregnancy and lactation is unknown. In this study, intestinal 
plasma membrane calcium ATPase [PMCAl], calcium binding protein 
[CaBP-9K] and vitamin D receptor [VDR] mRNA levels were determined 
by Northern blotting analysis at different stages of pregnancy and early 
lactation in rats. Intestinal calcium ATPase and calcium binding protein 
mRNA levels did not differ significantly among non-pregnant rats and rats 
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pregnant for 7 or 14 days. However, at 21 days gestation, both calcium 
ATPase and calcium binding protein mRNA levels increased 2- to 3-fold. 
Calcium ATPase and calcium binding protein mRNA remained elevated at 
7 days of lactation. Plasma 1,25-dihydroxyvitamin D3 [1,25-D3] 
concentration exhibited a similar pattern, rising markedly at 21 days 
gestation and remaining elevated in lactation. Interestingly, VDR mRNA 
levels did not change during the entire experiment. But intestinal VDR 
content increased 2-fold in late pregnancy and lactation. These data suggest 
that the adaptation to higher requirement for calcium in late pregnancy and 
early lactation stimulates transcription of calcium absorption factors and 
the effects of gestation and lactation on VDR are probably post 
transcriptional. 
Introduction 
Intestinal calcium transport across the rat intestine can be 
transcellular or paracellular (6). The transcellular pathway is believed to 
function primarily in the small intestine. In contrast, the paracellular 
pathway can occur anywhere in the intestine (44), but functions only when 
calcium can passively diffuse down a concentration gradient from the 
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lumen to the blood. Transcellular calcium transport is an active process 
and is described as occurring in three steps: 1. calcium diffusion across the 
brush border membrane of the enterocyte; 2. translocation of calcium from 
the brush border to the basolateral membrane; and 3. active extrusion of 
calcium across the basolateral membrane against a concentration gradient 
(8, 60). 
The entry of calcium into the ceU can occur by simple diffusion 
across the plasma membrane down its electrochemical gradient since 
lumenal calcium concentration is generally greater than intracellular 
calcium concentration. In addition, calcium may enter through voltage 
dependent or receptor operated chaimels coupled to second messengers, or 
through a Ca2+/Na+ exchanger (7). Once inside the cell, calcium moves to 
the basolateral membrane, either as free calcium ions, within vesicles, or 
bound to CaBP-9K (60). The concept of calbindin-9K as an intracellular 
calcium "carrier" is widely accepted. Intracellular calcium movement may 
be affected by other mobile organelles (37), but this transport is probably 
of relatively little importance. At the basolateral membrane, calcium 
ATPase plays a major role in extrusion of calcium (20). A Na+/Ca2+ 
exchanger also is present but contributes comparatively little to calcium 
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extrusion (36). 
The active metabolite of vitamin D, 1,25-D3, has long been known to 
be the principal regulator of transcellular calcium absorption processes (3, 
38, 52). It acts directly on the intestinal mucosal cells by a classical steroid 
hormone receptor-mediated process (13, 34) to induce the transcription 
and translation of proteins such as calcium binding protein (2, 3, 17, 33, 
35, 39, 44, 52, 55, 61), CaATPase (15, 18,42, 53, 57, 58) and vitamin D 
receptor (22, 47). 
The active transport of calcium by the intestinal tract is increased 
when larger amounts of calcium are required during such physiological 
states as pregnancy and lactation (5,19, 32, 56). The purpose of this study 
was to determine which components of the active calcium transport system 
are activated during pregnancy and early lactation. 
Materials and methods 
Animals: Three-month-old female non-pregnant, 7, 14, or 21 days 
pregnant and 7 days lactating rats fed rat lab diet [1% Ca, 0.74% P] 
(#5012, PMI Feeds, Inc., St. Louis, MO) were used to perform the 
experiment. Female rats were bred at weekly intervals so that all rats could 
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be euthanized on the same day. All pregnant rats had at least 10 fetuses and 
all lactation rats were nursing at least 10 pups. Rats were euthanized by 
inhalation of 50:50 C02:02 followed by decapitation. Blood samples were 
collected into heparinized tubes. 
In one set of rats, the duodenum was removed for determination of 
VDR protein concentration by saturation binding analysis. In a second set 
of animals the proximal 15 cm of duodenum mucosa from each rat was 
obtained and frozen in liquid nitrogen for later mRNA analysis. 
Northern blotting: Plasma membrane CaATPase, calcium binding 
protein and vitamin D receptor mRNA levels were determined by 
Northem blotting. Total RNA was isolated by TRIzol and chloroform, 
precipitated and washed by isopropanol and ethanol (GIBCO, BRL, 
Gaithersburg, MD). PolyA selection for detecting VDR mRNA was 
accomplished by streptavidin paramagnetic particles purchased from 
Promega, Madison, WI. RNA was fractionated on 1.2% formaldehyde 
agarose gel and transferred to nylon membranes (MSI Micro Separations 
Inc., Westboro, MA). The RNA on the membranes was cross-linked by 
UV Stratalinker 1800 (Stratagene, La Jolla, CA). A 3.4 kb cDNA from rat 
brain plasma membrane CaATPase [PMCAl], kindly supplied by Dr. Gary 
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Shull, University of Cincinnati, OH, was used to hybridize the membranes 
for analysis of CaATPase mRNA. The cDNA for CaBP-9K mRNA assay 
was the gift of Dr. M. Elizabeth Bruns, University of Virginia Medical 
School, Charlottesville, VA. The VDR cDNA was provided by Dr. Wes 
Pike, Ligand Pharmaceutical, La Jolla, CA. 
Membranes were prehybridized at 420 c for 4-6 hours in a 
prehybridization buffer containing 50% formamide, 5X Denhardt's 
reagent, 0.1% sodium dodecyl sulfate [SDS] and 100 ug/ml denatured fish 
sperm DNA. Fresh prehybridization buffer and 250 ug tRNA was used for 
the ovemight membrane hybridization with 5 x 10^ cpm 32p.iabeled 
cDNA probe/ml prehybridization buffer. The membranes were washed 
twice in 2 X SSPE/0.1% SDS buffer [SSPE is NaCl, NaH2P04, EDTA 
mixture], twice in 0.1 X SSPE/0.1% SDS, each for ten minutes. 
Quantitative analysis of mRNA was done by Electronic Autoradiography 
(PACKARD, Meriden, CT). A 2.1 kb chick P-actin cDNA probe was 
obtained by digestion of pBR322 with Hind HI (12) and used as a control 
for estimation of mRNA integrity and RNA sample loading difference 
among various preparations. 
Unoccupied VDR assay: Intestinal tissues were collected and mucosa 
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was harvested. Mucosa was washed 3 times in buffer [10 mM Tris, 1.5 mM 
ethylenediaminotetraacetic acid, 2 mM dithiothreitol and 200 ug/ml 
soybean trypsin inhibitor] with low speed centrifugation between each 
washing step (Costa and Feldman, 1986). A 20% homogenate [w/v] of the 
mucosa was prepared with a polytron (Brinkmann, Des Plaines, XL) in 
buffer containing 600 mM KCl. The homogenate was centrifuged at 
150,000 xg for 20 minutes to obtain cell cytosol. Unoccupied VDR was 
estimated by incubating the cell cytosol with 3.6 nM 1,25-D3 at 4° C for 18 
hours with gently shaking. Receptor bound 1,25-[26,27-3H]D3 was 
determined with hydroxyapatite. Specific binding was obtained by the 
difference between total binding and that observed in the presence of excess 
radio-inert 1,25-D3. Results are expressed in fmoles 1,25-D3 bound/mg 
cytosol protein [ftnole/mg]. 
Plasma 1,25-D3 determination: The method of Reinhardt et al 
(45) was modified to determine 1,25-D3 concentration in plasma (45). 
The plasma 1,25-D3 was chromatographed on C18/0H low hydrocarbon 
columns (Varian, Harbor City, CA), and the concentration determined by 
radio-receptor assay. Recovery of [3H]i,25-D3 was used to estimate 
recovery of 1,25-D3 through the purification steps for each sample. 
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Plasma calcium concentrations were determined by atomic 
absorption spectrophotometry (Perkin-Elmer Corporation. 1965 Analytical 
methods for atomic absorption spectrophotometry. Peikin-Elmer Corp., 
Norwalk, CT). 
Analysis of variance was used to determine if differences among 
CaATPase, CaBP and VDR mRNA levels and plasma constituents existed as 
a result of reproductive state. When ANOVA suggested differences 
existed, Dunnett multiple comparisons test was used to test the significance 
between individual stages of gestation. 
Results 
Intestinal CaATPase mRNA expression in the duodenum from 21-
day pregnant and 7-day lactation rats was increased 2.6- and 3.2-fold 
respectively above that in non-pregnant rats [p<0.01] (Figure 1, 2 and 
Table 1). Intestinal CaBP-9K mRNA expression in the duodenum of 21-
day pregnant and 7-day lactation rats was increased 2.1- and 3.2-fold above 
non-pregnant rats [p<0.05 and 0.01], respectively, for CaBP mRNA 
(Figure 3, 4 and Table 2). Northem blots of CaATPase exhibited a 3-band 
pattem of hybridization with a major band corresponding to 6 kb, which 
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is similar to previous reports (Figure 2) (37). There was no significant 
increase in CaATPase or CaBP mRNA at 7 or 14 days of gestation. 
Intestinal VDR mRNA did not change at any time during the entire period 
of gestation and lactation (Figure 5,6 and Table 3). However, intestinal 
VDR content increased significantly in late pregnancy and lactation 
[p<0.05] (Figure 7 and Table 4). Peak plasma 1,25-D3 elevation was at 21 
days of pregnancy, increasing from the control level of 35.6 pg/ml to 
165.5 pg/ml [p<0.001], and remained high during lactation [p< 0.01] 
(Figure 8 and Table 5). Plasma calcium concentration decreased from 11.2 
mg% in non-pregnant rats to 8.0 mg% in 21-day pregnancy [p< 0.01], and 
remained low at the 7th day of lactation (Figure 9 and Table 6). 
Discussion 
Active transport of calcium across the intestinal epithelial cells is 
dependent on the active metabolite of vitamin D, 1,25- D3 (14, 60, 63). 
The increased concentrations of plasma 1,25-D3 during late pregnancy and 
early lactation allows the dam to adapt to the large calcium demands of the 
fetus and lactation. Other factors such as estrogen may be involved because 
an increase in calcium transport rate in vitamin D-deficient pregnant rats 
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has also been observed (5). However, this increase was significantly lower 
than in vitamin D-repleted pregnant rats (5, 27). The fetus accumulates 
most of its body calcium over the last one third of gestation (21), and loss 
of calcium to milk during lactation represents an even greater calcium 
demand. Increased concentrations of plasma 1,25-D3 during late 
pregnancy and early lactation have been reported in rats and human (28, 
43, 62). Interestingly, pregnancy evidently does not change the circulating 
levels of 1,25- D3 in the sheep (41). Our data indicate a 3- to 4-fold 
increase of plasma 1,25-D3 during late pregnancy and early lactation, 
which is in agreement with earlier reports (28, 43). 
The calcium binding proteins [CaBP-9K], present in mammalian 
intestine, and CaBP-28K, in mammalian kidney, avian kidney and intestine 
are the most extensively studied products of genes affected by 1,25-D3 (4, 
11,16, 24, 31, 51, 54). The induction of these gene products generally 
coincides with increased calcium transport (25, 59). The rat placental 
CaBP-9K was reported to be upregulated during late pregnancy (21). 
Previous reports have suggested that intestinal CaBP-9K mRNA was 
upregulated only in early lactation and not in pregnancy (30). CaATPase 
extmdes calcium from the basolateral membrane of intestinal cells to the 
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extracellular fluids (9, 48). At least four genes have been found to code 
for plasma membrane CaATPase (9, 29). These isoforms of plasma 
membrane CaATPase [PMCA] include PMCAl, PMCA2, PMCA3 and 
PMCA4. All four isoforms of PMCA and their mRNAs have been 
identified in rats (23, 29, 49). PMCAl mRNA was expressed in virtually 
aU tissues, whereas other isoforms of PMCA were tissue-specific (23). In 
rat and human intestine, PMCAl is the predominant CaATPase isoform 
(23, 29) and is regulated by vitamin D (54, 63). A rat placental CaATPase 
mRNA was also shown to be upregulated during late pregnancy and early 
lactation (21); but little is known of changes in rat intestinal CaATPase 
mRNA expression during late pregnancy and early lactation. 
Interestingly, our results indicated that VDR mRNA did not change 
during pregnancy and lactation. However, unoccupied VDR number 
nearly doubled during late pregnancy and lactation. This suggested that the 
effects of pregnancy and lactation on VDR appears to change VDR 
metabolism by post transcriptional and nongenomic mechanisms that are 
consistent with reports of prolongation of the half life of the receptor in 
the occupied state (1, 50). 
Our studies demonstrate a 2-3 fold increase in both vitamin D-
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dependent intestinal CaATPase and CaBP-9K mRNA in 21-day pregnant 
and 7-day lactation rats. The increased expression of calcium ATPase and 
calcium binding protein mRNA implies that active transport systems of 
calcium in the intestine are activated when a sudden, large amount of 
calcium is required, such as during late pregnancy when the fetus 
accumulates calcium in bones and other soft tissues and early lactation of 
animals when large amounts of calcium are "lost" in milk. CaBP and 
CaATPase activities may be enhanced to compensate for physiological 
losses of large amount of calcium during late pregnancy and early 
lactation. 
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Appendix with mean data tables 
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Figure 3. Intestinal CaBP mRNA expression 
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Figure 4. Northern blot of intesrinal CaBP mRNA 
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Figure 5. Intestinal VDR mRNA expression 
in pregnancy and lactation 
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Table 1. Intestinal CaATPase mRNA [relative value] 
Days ralative to parturition Mean SD 
-21 1.00 0 
-14 1.03 0.37 
-7 1.72 0.45 
0 2.39* 0.67 
7 3.21** 0.75 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
125 
Table 2. Intestinal CaBP mRNA [relative value] 
Days ralative to parturition Mean SD 
-21 1.00 0 
-14 0.91 0.25 
-7 1.38 0.25 
0 2.11** 0.47 
7 3.21** 1.03 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
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Table 3. Intestinal VDR mRNA [relative value] 
Days ralative to parturition Mean SD 
-21 1.00 0 
-14 1.12 0.30 
-7 1.10 0.46 
0 1.18 0.37 
7 1.15 0.28 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
127 
Table 4. Intestinal VDR number 
[fmol/mg of protein] 
Days ralative to parturition Mean SD 
-21 343 57 
-2 610* 30 
14 645* 32 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
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Table 5. Plasma 1,25-D3 concentration [pg/ml] 
Days ralative to parturition Mean SD 
-21 35.6 14.1 
-14 30.9 11.6 
-7 29.8 11.8 
0 165.5*** 30.8 
7 103.8** 38.4 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
*** p<0.001 compared to control group 
Each group contains 4 rat samples. 
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Table 6. Plasma calciimi concentration [mg/dl] 
Days ralative to parturition Mean SD 
-21 11.2 1.0 
-14 10.0 0.9 
-7 10.8 0.4 
0 8.0* 1.6 
7 8.9 1.7 
* p<0.05 compared to control group 
** p<0.01 compared to control group 
Each group contains 4 rat samples. 
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GENERAL CONCLUSIONS 
1. Administration of 1,25-D3 to vitamin D-deficient rats yielded a 
time-dependent upregulation of intestinal CaATPase and CaBP mRNA. We 
conclude that vitamin D is a major regulator of intestinal calcium 
transporting factors. 
2. Large doses of 1,25,28-D2 may induce CaATPase and CaBP 
mRNA. The results indicate that larger doses of 1,25-D3 analog, 1,25,28-
D2, can also enhance transcriptional regulation of CaATPase and CaBP. 
3. Vitamin D-deficiency downregulates CaATPase and CaBP mRNA. 
Calcium deficiency did not induce transcriptional upregulation of 
CaATPase and CaBP in our experiments. We suggest that vitamin D, not 
calcium, is a major transcriptional regulator of CaATPase and CaBP. 
4. Pregnancy and lactation stimulate intestinal CaATPase and CaBP 
expression, implying the active transport systems are activated during late 
pregnancy and early lactation of animals. 
5. Intestinal VDR mRNA did not increase during late pregnancy and 
early lactation. However, intestinal VDR numbers increase significantly. 
This observation suggests post transcriptional regulation of VDR. 
